CRIIMI MAE INC
S-3, 1997-12-02
REAL ESTATE INVESTMENT TRUSTS
Previous: SCOTSMAN INDUSTRIES INC, 424B3, 1997-12-02
Next: NEW FRONTIER MEDIA INC /CO/, 10QSB, 1997-12-02



<PAGE>

 This Registration Statement also constitutes Post-Effective Amendment No. 3 to
                         Registration Statement No. 33-55583
    As filed with the Securities and Exchange Commission on December 2, 1997.
                                                               
                                                        Registration No.  -     
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------


                          SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C.  20549

                                   _______________

                                       FORM S-3
                                REGISTRATION STATEMENT
                                        Under
                              The Securities Act Of 1933

                                   _______________

                                   CRIIMI MAE Inc.
                (Exact name of Registrant as specified in its charter)

          Maryland                                    52-1622022
    (State of incorporation)                       (I.R.S. Employer    
                                                  Identification No.)
                                                  William B. Dockser
                                                 Chairman of the Board
        11200 Rockville Pike                     11200 Rockville Pike
     Rockville, Maryland  20852               Rockville, Maryland  20852
         (301) 816-2300                              (301) 816-2300
(Address, including zip code,             (Name, address, including zip code,
   and telephone number,                          and telephone number,
   including area code, of                         including area code,
Registrant's principal executive offices)          of agent for service)


                                       Copy to:

                              Morris F. DeFeo, Jr., Esq.
                             Swidler & Berlin, Chartered
                             3000 K Street, NW, Suite 300
                                Washington, DC  20007

    Approximate date of commencement of proposed sale to the public:  As soon
as practicable on or after the effective date of this Registration Statement.
                                   _______________

    If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box./ /
                                   _______________

    If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box./X/
  
    If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering./ /

    If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering./ / 

    If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box./ /

<PAGE>

                           CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
                                                           Proposed           Proposed Maximum        Amount of
Title of Each Class of Securities     Amount to be      Maximum Offering      Aggregate Offering     Registration
      to be Registered(1)              Registered       Price Per Unit(2)           Price             Fee
<S>                                 <C>                 <C>                   <C>                    <C>
Common Stock, par value $.01 per    5,000,000 shares         $14.81               $62,957,665          $19,078.08  
share                                                                                                       (3)

</TABLE>

(1) The Prospectus relates to this Registration Statement and Registration 
    Statement No. 33-55583 relating to the current CRIIMI MAE Inc. Dividend 
    Reinvestment and Stock Purchase Plan. It is estimated that the transition 
    from the current CRIIMI MAE Inc. Dividend Reinvestment and Stock Purchase
    Plan to the Plan described herein will be effected on or about December 26,
    1997 and that approximately 748,976 shares of Common Stock previously 
    registered but remaining unsold will be carried forward.

(2) Estimated solely for the purpose of calculating the registration fee in
    accordance with Rule 457(c) of the Securities Act of 1933, as amended, 
    based upon the average of the high and low prices of the Common Stock on 
    November 28, 1997, as reported on the New York Stock Exchange.

(3) Pursuant to Rule 429 of the Securities Act of 1933, as amended, the
    Prospectus included herein also covers 748,976 shares of Common Stock from
    a previous Registration Statement (No.33-55583), as to which a registration
    fee has previously been paid.

    Pursuant to Rule 429 under the Securities Act of 1933, as amended, the 
Prospectus included herein also covers 748,976 shares of Common Stock of the 
Registrant registered under Registration Statement No. 33-55583, as amended 
by Post-Effective Amendment No. 1 filed on September 23, 1994 and 
Post-Effective Amendment No. 2 filed on March 1, 1996.  In the event any of 
the previously registered Common Stock is offered prior to the effective date 
of this Registration Statement, it will not be included in any Prospectus 
hereunder. The amount of Common Stock of the Registrant being registered 
hereby, together with the Common Stock registered under Registration 
Statement No. 33-55583, represents the maximum amount of Common Stock of the 
Registrant which is expected to be offered for sale.

    The Registrant hereby amends this Registration Statement on such date or 
dates as may be necessary to delay its effective date until the Registrant 
shall file a further amendment which specifically states that this 
Registration Statement shall thereafter become effective in accordance with 
Section 8(a) of the Securities Act of 1933, as amended, or until the 
Registration Statement shall become effective on such date as the Commission, 
acting pursuant to said Section 8(a), may determine.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
                                          2
<PAGE>


 
Information contained herein is subject to completion or amendment.  A 
registration statement relating to these securities has been filed with the 
Securities and Exchange Commission.  These securities may not be sold nor may 
offers to buy be accepted prior to the time the registration statement 
becomes effective.  This prospectus shall not constitute an offer to sell or 
the solicitation of an offer to buy nor shall there be any sale of these 
securities in any State in which such offer, solicitation or sale would be 
unlawful prior to registration or qualification under the securities laws of 
any such State.

                    SUBJECT TO COMPLETION, DATED DECEMBER 1, 1997
PROSPECTUS                                                                {LOGO}

                                   CRIIMI MAE INC.
                    Dividend Reinvestment and Stock Purchase Plan
                                           
    CRIIMI MAE Inc. ("CRIIMI MAE" or the "Company") hereby offers 
participation in its Dividend Reinvestment and Stock Purchase Plan (the 
"Plan"). The Plan is designed to provide investors with a convenient and 
economical way to purchase shares of CRIIMI MAE's Common Stock, par value 
$.01 per share ("Common Shares"), without paying any service fees, brokerage 
commissions or other charges, and to reinvest all or a portion of their cash 
dividends in additional Common Shares, in most cases at a discount to the 
market price. Participants in the Plan and interested investors may:

    -    Invest by making optional cash payments at any time up to a maximum of
         $10,000 per month, regardless of whether the participants' dividends
         are being reinvested.

    -    Make an initial cash investment up to a maximum of $10,000.

    -    Invest by making an initial cash investment in excess of $10,000, or
         optional cash payments in excess of $10,000 per month, subject to
         permission of the Company, regardless of whether the participants'
         dividends are being reinvested.

    -    Automatically reinvest cash dividends on all or a portion of their
         Common Shares.

    To fulfill the Plan's requirements, Common Shares may be purchased in the 
open market, in privately negotiated transactions or from the Company. Common 
Shares purchased in the open market or in privately negotiated transactions 
will be credited to participant accounts at the average price per share of 
all Common Shares purchased with respect to the relevant Dividend 
Reinvestment Date or Investment Date, as applicable, less any applicable 
discount. When the Company elects to make Common Shares available for 
purchase under the Plan, the purchase price of the Common Shares so purchased 
will be the average of the daily high and low sales prices of the Common 
Shares as reported on the New York Stock Exchange Composite Tape (i) with 
respect to Common Shares purchased with reinvested dividends, on the five 
Trading Days prior to the Dividend Reinvestment Date less any discount and 
(ii) with respect to Common Shares purchased with optional cash payments or 
initial cash investments, on the ten Trading Days prior to the Investment 
Date (in the case of optional cash payments less any discount). The price to 
participants of Common Shares purchased with reinvested dividends or with 
optional cash payments that do not exceed $10,000 will reflect a discount, 
initially, of 2% from the market price. Common Shares purchased with optional 
cash payments exceeding $10,000 (as approved by the Company) may reflect a 
discount ranging from 0% to 5%. No discount will be offered on Common Shares 
purchased under the Plan with initial cash investments.

    The closing price of the Common Shares on November 28, 1997, as reported on
the New York Stock Exchange ("NYSE"), was $14.8125 per share.

    This Prospectus relates to 5,000,000 Common Shares offered for purchase
under the Plan. We suggest that you read the Prospectus carefully and retain it
for future reference.

    Holders of Common Shares who do not choose to participate in the Plan will
continue to receive cash dividends, as declared, in the usual manner.

       THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
          AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS
            THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
         COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS.
              ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
                                           
                                            
                   The date of this Prospectus is December __, 1997 

<PAGE>

                                AVAILABLE INFORMATION

    CRIIMI MAE and certain of its subsidiaries are subject to the 
informational requirements of the Securities Exchange Act of 1934, as amended 
(the "Exchange Act"), and in accordance therewith file reports, proxy 
statements and other information with the Securities and Exchange Commission 
(the "SEC" or "Commission").  Reports, proxy statements and other information 
filed by CRIIMI MAE can be inspected and copied at the SEC's Public Reference 
Room, 450 Fifth Street, NW, Washington, D.C. 20549 and the SEC's Regional 
Offices at 7 World Trade Center, 13th Floor, New York, New York 10048 and 500 
West Madison Street, Suite 1400, Chicago, Illinois 60661; and copies of such 
material can be obtained from the Public Reference Section of the SEC, 450 
Fifth Street, NW, Washington, D.C. 20549, at prescribed rates.  In addition, 
reports, proxy material and other information concerning CRIIMI MAE may be 
inspected at the NYSE, 20 Broad Street, New York, New York 10005 or reviewed 
through the Commission's Electronic Data Gathering Analysis and Retrieval 
System, which is publicly available through the Commission's Web Site 
(http://www.sec.gov).

    This Prospectus constitutes part of a Registration Statement on Form S-3 
(together with all amendments and exhibits, the "Registration Statement") 
filed by CRIIMI MAE with the SEC under the Securities Act of 1933, as amended 
(the "Securities Act").  This Prospectus does not contain all of the 
information included in the Registration Statement, certain parts of which 
are omitted in accordance with the rules and regulations of the SEC.  
Reference is made to the Registration Statement for further information with 
respect to CRIIMI MAE and the Common Shares.  Statements contained in this 
Prospectus concerning the provisions or contents of any contract, agreement 
or any other document referred to herein are not necessarily complete. With 
respect to each such contract, agreement or document filed as an exhibit to 
the Registration Statement, reference is made to such exhibit for a more 
complete description of the matters involved, and each such statement shall 
be deemed qualified in its entirety by such reference to the copy of the 
applicable document filed with the SEC. The Registration Statement, including 
the exhibits and schedules thereto, may be inspected without charge at the 
SEC's principal office at 450 Fifth Street, NW, Washington, D.C. and copies 
of it or any part thereof may be obtained from such office, upon payment of 
the fees prescribed by the SEC.

                   INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

    The following documents heretofore filed by CRIIMI MAE with the SEC (File
No. 1-10360) are incorporated herein by reference:

         1.   Annual Report on Form 10-K for the year ended December 31, 1996.
         2.   Quarterly Reports on Form 10-Q for the quarters ended March 31,
              1997, June 30, 1997 and September 30, 1997.
         3.   Definitive Proxy Statements dated April 28, 1995 and April 6,
              1993.
         4.   Form 8-K, as filed with the SEC on November 19, 1997.
         5.   Form 8-K, as filed with the SEC on October 3, 1997.
         6.   Form 8-A, as filed with the SEC on October 16, 1989.
         7.   Form 8-B, as filed with the SEC on October 27, 1993.

    All documents filed by CRIIMI MAE pursuant to Sections 13(a), 13(c), 14 
or 15(d) of the Exchange Act after the date of this Prospectus and prior to 
the termination of the offering of the Common Shares offered hereby shall be 
deemed to be incorporated by reference in this Prospectus from the date of 
filing of such documents. Any statement contained herein or in a document 
incorporated or deemed to be incorporated by reference herein shall be deemed 
to be modified or superseded for purposes of this Prospectus to the extent 
that a statement contained herein or in any other subsequently filed document 
which also is or is deemed to be incorporated by reference herein modifies or 
supersedes such statement. Any such statement so modified or superseded shall 
not be deemed, except as so modified or superseded, to constitute a part of 
this Prospectus.

    CRIIMI MAE will provide without charge to each person, including any 
beneficial owner, to whom a copy of this Prospectus has been delivered, on 
the written or oral request of any such person, a copy of any or all of the 
documents referred to above which have been or may be incorporated in this 
Prospectus by reference, other than exhibits to such documents, unless such 
exhibits are specifically incorporated by reference.  Requests for such 
copies should be directed to CRIIMI MAE's principal executive offices: CRIIMI 
MAE Inc., Investor Services, 11200 Rockville Pike, Rockville, Maryland 20852, 
or telephone (301) 816-2300 or toll-free (800) 266-0535.
 
                                          2
<PAGE>

                                 SUMMARY OF THE PLAN

    The following is a summary of certain features of the Plan and is 
qualified in its entirety by, and should be read in conjunction with, the 
more detailed information appearing elsewhere in this Prospectus.  
Capitalized terms that are used but not defined in this summary have the 
meanings given to them in "CRIIMI MAE Inc. Dividend Reinvestment and Stock 
Purchase Plan--Definitions."     

    The Plan provides holders of Common Shares and other investors with a 
convenient and economical way to purchase Common Shares through the 
reinvestment of all or a portion of their cash dividends in additional Common 
Shares. There is no minimum or maximum limitation on the amount of cash 
dividends a participant may reinvest under the Plan. In addition to 
reinvestment of dividends, participants in the Plan may invest additional 
funds through optional cash payments of not less than $100 and not more than 
$10,000 per month (except in cases covered by a Request for Waiver, as 
discussed below). Persons not currently holders of the Company's Common 
Shares may become participants by making an initial cash investment of not 
less than $500 and not more than $10,000 to purchase Common Shares through 
the Plan (except in cases covered by a Request for Waiver, as described 
below). For purposes of these limitations, all Plan accounts under the common 
control or management of a participant may be aggregated at the Company's 
sole discretion. Optional cash payments that exceed $10,000 and initial cash 
investments that exceed $10,000 may be made only upon acceptance by the 
Company of a completed Request for Waiver form. Participants may also make 
optional cash payments by having their bank checking accounts debited 
directly on a monthly basis (without charge to participants) to purchase 
Common Shares through the Plan.

    To fulfill Plan requirements, Common Shares may be purchased in the open 
market or in privately negotiated transactions, or directly from the Company. 
Common Shares purchased with reinvested dividends or with optional cash 
payments that do not exceed $10,000 will be issued at a discount, initially, 
of 2% to the market price of Common Shares. This discount is subject to 
change from time to time or may be discontinued at the Company's discretion, 
without prior notice to participants, after a review of current market 
conditions, the level of participation in the Plan and the Company's current 
and projected capital needs. The Company may establish a different discount 
(ranging from 0% to 5%, the "Waiver Discount") regarding Common Shares 
purchased from the Company with optional cash payments exceeding $10,000 that 
are approved by the Company pursuant to a Request for Waiver. CRIIMI MAE 
reserves the right to modify the pricing or any other provision of the Plan 
at any time. No participant shall have any authority or power to direct the 
time or price at which or the manner by which Common Shares may be purchased. 
There will be no discount on Common Shares purchased with initial cash 
investments.

    Each month, at least three Trading Days prior to the first day of the 
relevant Pricing Period, the Company may establish a Waiver Discount 
applicable to optional cash payments exceeding $10,000 and a minimum price 
(the "Threshold Price") applicable to all optional cash payments and all 
initial cash investments. The Waiver Discount, which may vary each month from 
0% to 5%, will be established in the Company's sole discretion after a review 
of current market conditions, the level of participation in the Plan and the 
Company's current and projected capital needs. The Threshold Price will apply 
to Common Shares purchased through the Plan directly from the Company but 
will not apply to Common Shares purchased in the open market or through 
negotiated transactions. Further, the reinvestment of dividends in additional 
Common Shares will not be subject to such Threshold Price, if any.

    Common Shares purchased for the Plan directly from the Company with 
reinvested dividends will be acquired on the relevant Dividend Reinvestment 
Date at a price to participants, computed to four decimal places, obtained by 
averaging the daily high and low sales price of the Common Shares on the New 
York Stock Exchange Composite Tape on the five Trading Days immediately 
preceding the relevant Dividend Reinvestment Date, less a discount of 2% (or 
such other discount, if any, then in effect). Common Shares purchased for the 
Plan directly from the Company with optional cash payments and initial cash 
investments will be acquired on the relevant Investment Date at a price to 
participants, computed to four decimal places, obtained by averaging the 
daily high and low sales price of the Common Shares on the New York Stock 
Exchange Composite Tape on the ten Trading Days immediately preceding the 
relevant Investment Date, in the case of optional cash payments less any 
discount. In the event that the Threshold Price is not 

                                          3
<PAGE>

satisfied for a Trading Day during the Pricing Period, then such Trading Day 
and the trading prices for that day will be excluded from (i) the Pricing 
Period and (ii) the determination of the purchase price of the Common Shares 
for all Common Shares purchased with optional cash payments and initial cash 
investments on that Investment Date. Thus, for example, if the Threshold 
Price is not satisfied for three of the ten Trading Days in the Pricing 
Period, then the purchase price of the Common Shares purchased directly from 
the Company with optional cash payments and initial cash investments on the 
Investment Date will be based upon the remaining seven Trading Days for which 
the Threshold Price was satisfied. 

    With respect to optional cash payments that exceed $10,000, for each 
Trading Day of the related Pricing Period on which the Threshold Price is not 
satisfied, one-tenth of a participant's optional cash payment will be 
returned to the participant without interest. No part of a participant's 
optional cash payment that does not exceed $10,000 or an initial cash 
investment of any amount will be returned for any Trading Day of the related 
Pricing Period on which the Threshold Price is not satisfied. Rather, the 
full amount of the optional cash payment that does not exceed $10,000 or 
initial cash investment will be used to purchase Common Shares (excluding 
from the calculation of the purchase price, however, any Trading Day on which 
the Threshold Price is not satisfied).

    In deciding whether to approve a Request for Waiver, the Company will 
consider relevant factors including, but not limited to, whether the Plan is 
then acquiring newly issued or treasury shares directly from the Company or 
acquiring Common Shares from third parties in the open market or in privately 
negotiated transactions, the Company's needs for additional funds, the 
attractiveness of obtaining such additional funds through the sale of Common 
Shares as compared to other sources of funds, the purchase price likely to 
apply to any sale of Common Shares under the Plan, the participant submitting 
the request, the extent and nature of such participant's prior participation 
in the Plan, the number of Common Shares held by such participant and the 
aggregate amount of optional cash payments and initial cash investments for 
which Requests for Waiver have been submitted by all participants. If such 
requests are submitted for any Investment Date for an aggregate amount in 
excess of the amount the Company is then willing to accept, the Company may 
honor such requests in order of receipt, pro rata or by any other method that 
the Company in its sole discretion determines to be appropriate.

    From time to time, financial intermediaries, including brokers and 
dealers, and other persons may engage in positioning transactions in order to 
benefit from the discount from the market price of the Common Shares acquired 
under the Plan. Such transactions may cause fluctuations in the trading 
volume of the Common Shares. Financial intermediaries and such other persons 
that engage in positioning transactions may be deemed to be underwriters 
within the meaning of Section 2(11) of the Securities Act. The Company has no 
arrangements or understandings, formal or informal, with any person relating 
to the sale of Common Shares to be received pursuant to the Plan.

    Subject to the availability of Common Shares registered for issuance 
under the Plan, there is no total maximum number of Common Shares that can be 
issued pursuant to the reinvestment of dividends and no preestablished 
maximum limit applicable to optional cash payments and initial cash 
investments that may be made pursuant to Requests for Waiver. As of the date 
hereof, 5,000,000 Common Shares have been registered and are available for 
sale under the Plan.

    Participants in the Plan will pay no commissions or brokerage fees on 
open market purchases of Common Shares made in connection with dividend 
reinvestments, optional cash payments and initial cash investments.  All 
costs of administering the Plan and all fees, commissions and expenses 
incurred in connection with any open market purchases made pursuant to the 
Plan will be paid by CRIIMI MAE.

    If a participant wishes to sell Common Shares held in the Plan, the 
participant may elect to have such Common Shares sold through the Plan.  
Common Shares sold through the Plan will be effected by the Agent through a 
registered broker-dealer and will be subject to an administrative charge of 
$10.00, applicable brokerage fees and commissions and transfer taxes, if any. 
 A participant that wishes to sell Common Shares held in the Plan other than 
through the Plan may request that the Agent deliver a certificate for such 
Common Shares to the participant, which the participant may then sell through 
his or her registered broker-dealer.

    Participants in the Plan who reinvest dividends will be treated for 
federal income tax purposes as having received 

                                          4
<PAGE>

a dividend (to the extent the Company has current or accumulated earnings and 
profits) equal to (i) in the case of Common Shares purchased from the 
Company, the fair market value of Common Shares received, and (ii) in the 
case of Common Shares purchased on the open market, the amount of cash 
provided by the Company to purchase the Common Shares plus the amount of any 
brokerage commissions paid by the Company with respect to the Common Shares, 
without receiving cash to pay any tax payment obligation which arises as a 
result of such dividend. Participants in the Plan who make optional cash 
payments will be treated for federal income tax purposes as having received a 
dividend equal to the excess of the fair market value on the Investment Date 
of such Common Shares over the amount of the optional cash payment made by 
the Participant. Participants will not be able to control the specific timing 
of optional cash payments, initial cash investments and sales of Common 
Shares under the Plan. The market discount for purchases of Common Shares may 
change from time to time or may be eliminated at any time. See "CRIIMI MAE 
Inc. Dividend Reinvestment and Stock Purchase Plan-- Disadvantages." 

                                          5
<PAGE>

                                      CRIIMI MAE

    CRIIMI MAE is a full service commercial mortgage company structured as a 
self-administered real estate investment trust ("REIT"). CRIIMI MAE 
specializes in the acquisition, origination, securitization and servicing of 
multifamily and commercial mortgages and mortgage-related assets throughout 
the United States.

            CRIIMI MAE INC. DIVIDEND REINVESTMENT AND STOCK PURCHASE PLAN

    The following is a complete statement of the Plan.

Purpose

    The purpose of the Plan is to provide holders of CRIIMI MAE's Common 
Shares and other investors with a convenient and economical way to purchase 
Common Shares and to reinvest all or a portion of their cash dividends in 
additional Common Shares.

    The Plan may also have the effect of raising additional capital through 
the direct sale of Common Shares by the Company. These sales may be effected, 
in part, through the Company's approval from time to time, in its sole 
discretion, of Requests for Waiver regarding the limitations applicable to 
the initial cash investment and optional cash payment features of the Plan.

Definitions

    The following is a list of certain capitalized terms and their meanings for
purposes of this Prospectus.

    -    Agent means Registrar and Transfer Company, the Company's agent and
         administrator for the Plan.

    -    Beneficial Owner means a holder of Common Shares who beneficially owns
         Common Shares that are registered in a name other than such holder's
         name (for example, where Common Shares are held in the name of a
         broker, bank or other nominee).

    -    Dividend Reinvestment Date means the first Trading Day after the date
         on which the Company pays quarterly dividends. Dividends on Common
         Shares have historically been paid on the last Trading Day of each
         quarter ended March 31, June 30, September 30 and December 31. 

    -    Holder of Record means a holder of Common Shares who owns Common
         Shares in his or her own name.

    -    Investment Date means for all optional cash payments and initial cash
         investments, including optional cash payments and initial cash
         investment exceeding $10,000, the eleventh Trading Day after the
         commencement of the Pricing Period each month.  Please see Schedule A
         for a list of the Investment Dates for each month through the month
         ending December 31, 1999.

    -    Pricing Period means, (i) with respect to optional cash payments and
         initial cash investments, the period encompassing the ten Trading Days
         immediately preceding the relevant Investment Date and (ii) with
         respect to the reinvestment of cash dividends, the period encompassing
         the five Trading Days immediately preceding the relevant Dividend
         Reinvestment Date.

    -    Threshold Price means the stated dollar amount that the average of the
         high and low sales price of the Common Shares on the New York Stock
         Exchange Composite Tape for a Trading Day in a Pricing Period must
         equal or exceed in order to be included in the calculation of the
         purchase price for newly issued Common Shares acquired from the
         Company. With respect to initial cash investments and optional cash
         payments (in each case regardless of dollar amount), if the Threshold
         Price is not satisfied for a Trading Day in the Pricing Period, then
         the high and low sales price for that Trading Day will be excluded
         from the calculation of the purchase price of Common Shares.  See
         "--Source and Price of Common Shares" below.

    -    Trading Day means a day on which trades of the Common Shares are
         reported on the NYSE.

                                          6
<PAGE>

Advantages

    -    Common Shares purchased under the Plan with reinvested dividends and
         optional cash payments that do not exceed $10,000, whether purchased
         in the open market or directly from the Company, will be issued
         commission free and at a discount, initially, of 2% to the market
         price.  If it is determined that Common Shares to be purchased under
         the Plan will be made in the open market instead of directly from the
         Company, participants will not pay any brokerage fees or commissions
         on open market purchases or in privately negotiated purchases of
         Common Shares.

    -    In addition to reinvestment of dividends, participants may invest
         additional funds in Common Shares through optional cash payments of
         not less than $100 and not more than $10,000 per month, unless a
         Request for Waiver is approved by the Company. Optional cash payments
         may be made by sending to the Agent a check or money order payable to
         "Registrar and Transfer Company." Optional cash payments may be made
         occasionally or at regular intervals, as the participant desires. 
         Participants may also make optional cash payments by having their bank
         checking accounts debited directly, without paying a fee, on a monthly
         basis to purchase Common Shares through the Plan. Participants may
         make optional cash payments even if dividends on their Common Shares
         are not being reinvested.

    -    Persons not currently holders of Common Shares may become participants
         by making an initial cash investment of not less than $500 and not
         more than $10,000, or a greater amount if a Request for Waiver is
         approved by the Company, to purchase Common Shares under the Plan.

    -    Funds invested in the Plan for Holders of Record are fully invested
         through the purchase of fractions of Common Shares, as well as full
         Common Shares, and proportionate cash dividends on fractions of Common
         Shares are used to purchase additional Common Shares.  See
         "--Participation Option" for a discussion of fractional shares owned
         by Beneficial Owners.

    -    A participant may make a gift, at any time and at a nominal cost to
         the participant, of all or a portion of the Common Shares held in the
         Plan in the name of the participant to a Plan account for another
         person by instructing the Agent of the request and enclosing a check
         for the processing fee made payable to the Agent.

    -    The Plan offers a "share safekeeping" service whereby participants may
         deposit their Common Share certificates with the Agent and have their
         ownership of such Common Shares maintained on the Agent's records as
         part of their Plan accounts. Participants will not be charged a fee
         for this service.

    -    Participants will not pay any service fees, brokerage commissions or
         other charges in connection with purchases of Common Shares under the
         Plan.

Disadvantages

    -    Participants in the Plan who reinvest dividends will be treated for
         federal income tax purposes as having received a dividend on the
         dividend payment date.  In addition, participants in the Plan who make
         optional cash payments will be treated for federal income tax purposes
         as having received a dividend at the time they receive Common Shares
         purchased with such optional cash payments to the extent of any 
         discount received as a result of such optional cash payments.  Such
         dividends may give rise to a tax payment obligation without providing
         the participant with immediate cash to pay such tax when it becomes
         due. See "Certain United States Federal Income Tax Considerations."

    -    Participants will not be able to control the specific timing of
         purchases and sales of Common Shares under the Plan. Because purchases
         under the Plan will be made no earlier than eleven Trading Days
         following receipt of an investment instruction, and because sales
         under the Plan will be effected by the Agent through a registered
         broker-dealer only as soon as practicable after the Agent receives
         such instructions, a participant may be unable to achieve the same
         level of control over purchase and sale timing that he or she might
         have regarding investments made outside the Plan.

    -    The Company may, without prior notice to participants, change or
         eliminate the discount on Common Shares to be purchased through the
         Plan pursuant to the dividend reinvestment and optional cash payment
         features. As a result, participants will generally be unable to depend
         on the availability of a market discount regarding Common Shares
         acquired through the Plan.

                                          7
<PAGE>

    -    No interest will be paid by the Company or the Agent to a participant
         on dividends, initial cash investments or optional cash payments held
         pending reinvestment or investment or to be returned to the
         participant. In addition, optional cash payments exceeding $10,000 per
         month may be subject to return to the participant (in whole or
         proportionate part) without interest in the event that (i) a Threshold
         Price has been established with respect to Common Shares to be
         purchased from the Company and (ii) such Threshold Price is not met
         for a Trading Day during the related Pricing Period.

    -    With respect to optional cash payments exceeding $10,000, while the
         Plan allows the Company to establish a discount from the average
         market price of the Common Shares during the Pricing Period, there can
         be no assurance that such average market price, as so discounted, will
         equal or exceed the market price of the Common Shares on the relevant
         Investment Date. Similarly, there can be no assurance that the average
         market price of Common Shares purchased with optional cash payments
         that do not exceed $10,000, less any discount (initially 2%), will
         equal or exceed the market price of the Common Shares on the relevant
         Investment Date.

Administration

    CRIIMI MAE has retained Registrar and Transfer Company as plan 
administrator and agent (the "Agent") to administer the Plan, keep records, 
send statements of account activity to each participant and perform other 
duties relating to the Plan.  Common Shares purchased under the Plan and held 
by the Agent will be registered in the Agent's name or the name of its 
nominee for the benefit of the participants. If the Agent resigns or 
otherwise ceases to act as plan administrator and agent, the Company will 
appoint a new plan administrator and agent to administer the Plan. 

    Questions regarding the Plan may be directed to the Agent either by phone
at (800) 998-9151 or in writing to the following address: 

         Registrar and Transfer Company
         Attention:  CRIIMI MAE Dividend Reinvestment and Stock Purchase Plan
         10 Commerce Drive
         Cranford, New Jersey  07016

Participation

    Participation in the Plan is open to any person or entity, whether or not 
a holder of Common Shares, provided that such person or entity fulfills the 
prerequisites for participation described below under "Enrollment 
Procedures." A holder of Common Shares who owns the Common Shares in his or 
her own name is referred to herein as a "Holder of Record." A Holder of 
Record may participate directly in the Plan. A holder of the Common Shares 
who beneficially owns Common Shares that are registered in a name other than 
such holder's name (for example, where Common Shares are held in the name of 
a broker, bank or other nominee) is referred to herein as a "Beneficial 
Owner." A Beneficial Owner may participate in the Plan by either (i) becoming 
a Holder of Record by having one or more Common Shares transferred into such 
holder's own name or (ii) coordinating such holder's participation with his 
or her broker, bank or other nominee who is the record holder to participate 
on such holder's behalf. A prospective investor who holds no Common Shares 
may participate, at his or her option, either directly or through a broker, 
bank or other nominee. See "--Enrollment Procedures" below.

    The Plan is intended for the benefit of investors in CRIIMI MAE and not 
for persons or entities who accumulate accounts under the Plan over which 
they have control for the purpose of exceeding the $10,000 per month maximum 
without seeking the advance approval of the Company or who engage in 
transactions that cause or are designed to cause aberrations in the price or 
trading volume of the Common Shares. Notwithstanding anything in the Plan to 
the contrary, CRIIMI MAE reserves the right to exclude from participation in 
the Plan, at any time, (i) persons or entities who attempt to circumvent the 
Plan's standard $10,000 per month maximum by accumulating accounts over which 
they have control or (ii) any other persons or entities, as determined in the 
sole discretion of the Company.

                                          8
<PAGE>

    Participants currently enrolled in the CRIIMI MAE Inc. Dividend 
Reinvestment and Stock Purchase Plan, the predecessor to the Plan, will 
automatically be enrolled in the Plan.  Participants currently enrolled in 
the CRIIMI MAE Inc. Dividend Reinvestment and Stock Purchase Plan who do not 
wish to enroll in the Plan may withdraw from the Plan by sending written 
notice to the Agent.  See "--Withdrawal."

Previous Sales Under the Plan

    Under the CRIIMI MAE Inc. Dividend Reinvestment and Stock Purchase Plan 
in effect from August 1990 until the adoption of this Plan by the Company's 
board of directors, the Company issued 251,024 Common Shares. A total of 
37,786 Common Shares were issued pursuant to the optional cash payment 
feature of such predecessor plan.

Enrollment Procedures

After being furnished a copy of this Prospectus:

         (a) Holders of Record may become participants by delivering a
    completed Enrollment Form to the Agent.  Participants currently enrolled in
    the CRIIMI MAE Inc. Dividend Reinvestment and Stock Purchase Plan need not
    do anything to continue their participation in the Plan. 

         (b) Beneficial Owners are eligible to participate in the reinvestment
    of dividends. However, Beneficial Owners must instruct their broker, bank
    or other nominee who is a Depository Trust Company ("DTC") participant to
    participate on their behalf in the Plan.  See "--Broker and Nominee Form."

         (c) Interested persons not currently holders of Common Shares may
    become participants by (i) directly delivering a completed Enrollment Form
    to the Agent or (ii) instructing their broker, bank or other nominee to
    deliver a completed and signed Enrollment Form to the Agent together with
    an initial cash investment of not less than $500 and not more than $10,000;
    provided, that initial cash investments of more than $10,000 may be made if
    a Request for Waiver therefor is approved by the Company.

    Enrollment Forms will be processed as promptly as practicable. 
Participation in the Plan will begin after the properly completed Enrollment 
Form has been reviewed and accepted by the Agent (and, in cases of initial 
cash investments exceeding $10,000, a properly completed Request for Wavier 
form has been reviewed and accepted by the Company).

Participation Option

    The Enrollment Form appoints the Agent as agent for the participants and 
directs the Company to pay to the Agent such participants' cash dividends on 
all or a specified number of Common Shares owned by the participants 
("Participating Shares"), as well as on all whole and fractional Common 
Shares credited to participants' Plan accounts ("Plan Shares"). The 
Enrollment Form directs the Agent to purchase, on the Dividend Reinvestment 
Date, additional Common Shares with such dividends. The Enrollment Form also 
directs the Agent to purchase on the relevant Investment Date additional 
Common Shares with optional cash payments and initial cash investments of not 
more than $10,000, if any, made by Holders of Record. See "--Cash Investments 
Exceeding $10,000" below for a discussion of the requirements for optional 
cash payments and initial cash investments exceeding $10,000. See "--Broker 
and Nominee Form" below for a discussion of the requirements for optional 
cash payments of a Beneficial Owner, and initial cash investments of an 
investor who is not currently a holder of Common Shares, whose broker, bank 
or other nominee holds or will hold such person's Common Shares. The 
Enrollment Form also directs the Agent to automatically reinvest all 
subsequent dividends on Plan Shares. Dividends will continue to be reinvested 
until the participant specifies otherwise by contacting the Agent, withdraws 
from the Plan or the Plan is terminated.

    The Enrollment Form provides for the purchase of additional Common Shares 
through the following investment 

                                          9
<PAGE>

options:

         (a) Full Dividend Reinvestment--The Agent will apply any cash
    dividends on all Common Shares held in certificate form by the participant
    and all cash dividends on Plan Shares, together with any optional cash
    payments or initial cash investment, toward the purchase of additional
    Common Shares.

         (b) Partial Dividend Reinvestment--The Agent will apply cash dividends
    on Common Shares held in certificate form by the participant and specified
    on the Enrollment Form, and all cash dividends on Plan Shares, together
    with any optional cash payments or initial cash investment, toward the
    purchase of additional Common Shares.

         (c) Optional Cash Payment and Initial Cash Investment Only--The
    participant will continue to receive cash dividends on Common Shares held
    in certificate form by the participant in the usual manner. However, the
    Agent will apply all cash dividends on all Plan Shares, together with any
    optional cash payments or initial cash investment received from the
    participant, toward the purchase of additional Common Shares.

    Each participant may select any one of these three options. In each case, 
dividends will be reinvested on all Participating Shares and on all Plan 
Shares held in the Plan account, including dividends on Common Shares 
purchased with any optional cash payments or initial cash investment, until a 
participant specifies otherwise by contacting the Agent, or withdraws from 
the Plan altogether, or until the Plan is terminated. If a participant would 
prefer to receive cash payments of dividends on Plan Shares rather than 
reinvest such dividends, those Common Shares must be withdrawn from the Plan 
by written notification to the Agent. See "--Withdrawal" below.

    Beneficial Owners may have their dividends reinvested in additional 
Common Shares if the Beneficial Owner's broker, bank or other nominee is a 
DTC participant. The Beneficial Owner should instruct his or her broker, bank 
or other nominee to provide instructions to DTC to reinvest all or a portion 
of his or her cash dividends. Common Shares issued as a result of reinvested 
dividends pursuant to a request by a Beneficial Owner will be in certificated 
form. A Beneficial Owner can make optional cash payments or an initial cash 
investment by instructing his or her broker, bank or other nominee to 
complete a Broker and Nominee Form and transmit funds to the Agent.  A 
Beneficial Owner that wishes to purchase Common Shares by making an optional 
cash payment or initial cash investment through a broker, bank or other 
nominee may not receive fractions of Common Shares, in which event uninvested 
cash will be returned via check to the broker, bank or other nominee on 
behalf of the Beneficial Owner.   See "--Broker and Nominee Form" below.

    The Enrollment Form also permits a participant to authorize automatic 
deductions from his or her personal bank checking account. If this option is 
selected, the Agent will automatically deduct from the participant's 
designated bank account the amount indicated on the Enrollment Form (not less 
than $100 or more than $10,000 per month) on or about the fifteenth day of 
each month. 

    A participant may change his or her investment option at any time by 
completing a new Enrollment Form and returning it to the Agent.

Broker and Nominee Form

    The Broker and Nominee Form provides the only means by which a broker, 
bank or other nominee holding Common Shares on behalf of a Beneficial Owner, 
or planning to hold Common Shares on behalf of an interested investor who is 
not currently a holder of Common Shares, may make optional cash payments or 
an initial cash investment within the minimum and maximum investment 
limitations established for the Plan (see "--Optional Cash Payments and 
Initial Cash Investments" below) on behalf of such Beneficial Owner or 
interested investor. A Broker and Nominee Form must be delivered to the Agent 
each time such broker, bank or other nominee transmits optional cash payments 
or an initial cash investment. Broker and Nominee Forms will be furnished at 
any time upon request to the 

                                          10
<PAGE>

Agent.

    The Broker and Nominee Form and appropriate instructions must be received 
by the Agent not later than 12:00 p.m. (noon) Eastern time on the Trading Day 
immediately preceding the commencement of the relevant Pricing Period in 
order to be invested on the Investment Date, otherwise the optional cash 
payment or initial cash investment will be returned, without interest.

    Common Shares issued pursuant to a properly completed Broker and Nominee 
Form will not be deemed Plan Shares. Therefore, subsequent dividends will be 
paid in cash unless otherwise instructed by the Beneficial Owner. See 
"--Enrollment Procedures" above for a discussion of the requirements for a 
Beneficial Owner participating in the reinvestment of dividends.

Reinvestment of Cash Dividends

    A participant may elect to reinvest cash dividends paid on all or a 
portion of the Common Shares held in certificate form by the participant by 
designating his or her election on the Enrollment Form. Reinvestment levels 
may be changed from time to time as a participant desires by submitting a new 
election to the Agent on a properly completed Enrollment Form. To be 
effective with respect to a particular dividend payment date, any change in 
the reinvestment election must be received by the Agent no later than three 
Trading Days before the record date for such dividend. The record date is 
usually about ten days prior to the dividend payment date. 

    Dividends on Common Shares are expected to be paid on the last Trading 
Day of each quarter ended March 31, June 30, September 30 and December 31. 
The reinvestment of dividends will generally begin on the Dividend 
Reinvestment Date and will normally extend over a period of two to five 
Trading Days in the case of open market purchases. Newly issued Common Shares 
will be purchased from CRIIMI MAE on the Dividend Reinvestment Date. If the 
participant has specified partial reinvestment of dividends or optional cash 
payment or initial cash investment only, the portion of such dividend payment 
not being reinvested will be sent to the participant by check in the usual 
manner.

Optional Cash Payments and Initial Cash Investments

    Participants in the Plan may make optional cash payments by personal 
check or money order made payable to "Registrar and Transfer Company." An 
optional cash payment may also be made by a broker, bank or other nominee 
acting on behalf of a Beneficial Owner. Optional cash payments must be at 
least $100 for any single investment and may not exceed $10,000 per month. 
(For purposes of these limitations, all Plan accounts under the common 
control or management of a participant may be aggregated, at the Company's 
sole discretion). Optional cash payments exceeding $10,000 per month may be 
made only upon acceptance by CRIIMI MAE of a properly completed Request for 
Waiver form. See "--Cash Investments Exceeding $10,000" below. There is no 
obligation to make an optional cash payment at any time, and the amount of 
such payments may vary from time to time. Participants may also make optional 
cash payments by arranging to have their bank checking accounts debited 
directly on a monthly basis to have Common Shares purchased through the Plan. 
To initiate direct debiting, a participant must complete the "Automatic Cash 
Investment" portion of the Enrollment Form and return to the Agent the 
Enrollment Form and a voided check on the account the participant wishes to 
be debited. Debits to participants' accounts will be processed on or about 
the fifteenth day of each month, but will not commence until the month 
following the Agent's receipt of the completed Enrollment Form and voided 
check. The minimum monthly account debit is $100 and the maximum is $10,000. 
Participants will not be charged a fee in connection with making optional 
cash payments by direct debit. Cash contributions may not be accepted by the 
Agent if a participant imposes any restrictions with respect to the number of 
Common Shares to be purchased, the price at which the Common Shares are to be 
purchased or the timing of the purchase.

    An interested person not currently a holder of Common Shares may become a 
participant by directly enrolling in the Plan by delivering a completed 
Enrollment Form to the Agent and making an initial cash investment in the 
form of a personal check or money order payable to "Registrar and Transfer 
Company." An interested person not currently 

                                          11
<PAGE>

a holder of Common Shares and not wanting to enroll directly in the Plan must 
instruct his or her broker, bank or other nominee to complete a Broker and 
Nominee Form and transmit the initial cash investment to the Agent. Initial 
cash investments must be at least $500 and may not exceed $10,000 (without 
the prior approval of the Company pursuant to a Request for Waiver). (For 
purposes of these limitations, all Plan accounts under the common control or 
management of a participant may be aggregated, at CRIIMI MAE's sole 
discretion). Initial cash investments exceeding $10,000 per month may be made 
only upon acceptance by the Company of a properly completed Request for 
Waiver form.

    Optional cash payments and initial cash investments that do not exceed 
$10,000 must be received by the Agent no later than 12:00 p.m. (noon) Eastern 
time on the Trading Day immediately preceding the commencement of the 
relevant Pricing Period, and any payment in the form of check or money order 
must have cleared on or before the Investment Date in order to be invested on 
the Investment Date. Optional cash payments and initial cash investments that 
are received or cleared after such time will be returned to the participant, 
without interest. OPTIONAL CASH PAYMENTS AND INITIAL CASH INVESTMENTS 
EXCEEDING $10,000 MUST BE RECEIVED (TOGETHER WITH A COMPLETED REQUEST FOR 
WAIVER FORM) BY THE AGENT IN GOOD FUNDS NOT LATER THAN 12:00 P.M. (NOON) 
EASTERN TIME ON THE TRADING DAY IMMEDIATELY PRECEDING THE COMMENCEMENT OF THE 
RELEVANT PRICING PERIOD IN ORDER FOR SUCH FUNDS TO BE INVESTED ON THE RELATED 
INVESTMENT DATE. Upon a participant's written request received by the Agent 
no later than two Trading Days prior to the Pricing Period, a timely optional 
cash payment or initial cash investment not already invested under the Plan 
will be canceled or returned to the participant, as appropriate. However, in 
such latter event, no refund of a check or money order will be made until the 
funds have been actually received by the Agent. Accordingly, such refunds may 
be delayed by up to three weeks.

    The Agent will establish an escrow account for the deposit of optional 
cash payments that exceed $10,000 and initial cash investments that exceed 
$10,000 pending their investment in Common Shares.  Interest that accrues on 
funds deposited in the escrow account pending their investment on the 
relevant Investment Date will be paid to CRIIMI MAE. No interest will be paid 
to CRIIMI MAE from funds deposited with the Agent in connection with optional 
cash payments not exceeding $10,000 and initial cash investments not 
exceeding $10,000. No interest will be paid to participants on amounts held 
by the Agent pending investment or to be returned to the participant. All 
optional cash payments and initial cash payments are subject to collection by 
the Agent for full face value in U.S. funds.

    The Agent will apply the optional cash payment or initial cash payment 
received from a participant to the purchase of Common Shares for the account 
of the participant on the relevant Investment Date. See "--Source and Price 
of Shares" and "--Cash Investments Exceeding $10,000" below.  See Schedule A 
for a list of Investment Dates.

Source and Price of Common Shares

    Source

    To fulfill the Plan's requirements, the Agent may purchase or sell Common 
Shares in the open market or in privately negotiated transactions subject to 
such terms and conditions, including price and delivery, as the Agent may 
accept. The Agent may also purchase Common Shares from CRIIMI MAE, to the 
extent CRIIMI MAE makes Common Shares available. The Agent may commingle each 
participant's funds with those of other participants for the purpose of 
executing purchases.

    For open market purchases in connection with optional cash payments and 
initial cash investments, Common Shares purchased by the Agent will be 
acquired through open market transactions conducted by a registered 
broker-dealer commencing on the first Trading Day that follows the end of the 
Pricing Period; open market purchases will typically extend over two to five 
Trading Days. Newly issued Common Shares acquired with optional cash payments 
and initial cash investments will be purchased from CRIIMI MAE on the 
Investment Date.

    Dividend and voting rights on Common Shares purchased in the open market 
will commence upon settlement, 

                                          12
<PAGE>

which is normally three Trading Days after purchase. However, Common Shares 
purchased in the open market within a period of three Trading Days prior to 
and including a dividend record date are considered purchased "ex-dividend" 
and therefore are not entitled to payment of that dividend.

    Price

    Reinvested Dividends.  Common Shares purchased in the open market 
pursuant to the reinvestment of dividends will be credited to participants' 
accounts at the weighted average price per share of all Common Shares 
purchased with respect to the relevant Dividend Reinvestment Date less a 
discount, initially, of 2%. Common Shares purchased for the Plan directly 
from CRIIMI MAE will be acquired on the Dividend Reinvestment Date at a price 
to participants, computed to four decimal places, obtained by averaging the 
daily high and low sales price of the Common Shares as reported on the New 
York Stock Exchange Composite Tape on the five Trading Days immediately 
preceding the Dividend Reinvestment Date and subtracting from such average a 
discount, initially, of 2%.

    Optional Cash Payments That Do Not Exceed $10,000.  Common Shares 
purchased in the open market with optional cash payments that do not exceed 
$10,000 will be credited to participants' accounts at the weighted average 
price per share of all Common Shares purchased with respect to the relevant 
Investment Date, less a discount, initially, of 2%. Common Shares purchased 
for the Plan directly from CRIIMI MAE with optional cash payments that do not 
exceed $10,000 will be acquired on the relevant Investment Date at a price to 
participants, computed to four decimal places, obtained by (i) averaging the 
daily high and low sales price of the Common Shares on the New York Stock 
Exchange Composite Tape on the Trading Days during the Pricing Period 
immediately preceding the relevant Investment Date on which the Threshold 
Price, if any, is satisfied and (ii) subtracting from such average a 
discount, initially, of 2%. See "--Cash Investments Exceeding $10,000--Waiver 
Discount and Threshold Price" for a discussion of the price of and discount 
for Common Shares purchased with optional cash payments that exceed $10,000.

    Initial Cash Investments.  Common Shares purchased in the open market 
with initial cash investments will be credited to participants' accounts at 
the weighted average price per share of all Common Shares purchased with 
respect to the relevant Investment Date. Common Shares purchased for the Plan 
directly from CRIIMI MAE with initial cash investments will be acquired on 
the relevant Investment Date at a price to participants, computed to four 
decimal places, obtained by averaging the daily high and low sales price of 
the Common Shares on the New York Stock Exchange Composite Tape on the 
Trading Days during the relevant Pricing Period on which the Threshold Price, 
if any, is satisfied. There is no discount for Common Shares purchased in the 
open market or directly from the Company with initial cash investments.

    Threshold Price.  Notwithstanding anything contained herein to the 
contrary, CRIIMI MAE may establish for each Pricing Period a Threshold Price 
applicable to the purchase of newly issued Common Shares purchased through 
optional cash payments and initial cash investments. The Threshold Price, if 
any, will be established by the Company, in its sole discretion, at least 
three Trading Days prior to the first day of the Pricing Period based upon a 
review of current market conditions and other relevant factors. Participants 
may obtain the applicable Threshold Price by telephoning the Company at (800) 
266-0535 and requesting "CRIIMI MAE Investor Services." The Threshold Price 
will be a stated dollar amount that the average of the high and low sales 
price of the Common Shares on the New York Stock Exchange Composite Tape for 
a Trading Day of the Pricing Period must equal or exceed in order to be 
included in the calculation of the purchase price for newly issued Common 
Shares acquired from CRIIMI MAE. In the event that such Threshold Price is 
not satisfied for a Trading Day of the Pricing Period, then such Trading Day 
and the trading prices of the Common Shares for that day will be excluded 
from (i) the Pricing Period and (ii) the determination of the purchase price 
of the Common Shares for all optional cash payments and initial cash 
investments. Thus, for example, if the Threshold Price is not satisfied for 
three of the ten Trading Days in the Pricing Period, then the purchase price 
of the Common Shares will be based upon the remaining seven Trading Days for 
which the Threshold Price was satisfied.  

    No portion of any optional cash payment that does not exceed $10,000, and 
no portion of any initial cash investment, will be returned to participants 
for any Trading Day of a Pricing Period for which the Threshold Price is 

                                          13
<PAGE>

not satisfied. 

    See Schedule A for a list of Investment Dates and associated optional 
cash payment and initial cash investment due dates and Pricing Periods.

    The discount for purchases of Common Shares with optional cash payments 
that do not exceed $10,000 and reinvested dividends will initially be 2% but 
may be changed or eliminated by CRIIMI MAE, without prior notice to 
participants, at any time.

Cash Investments Exceeding $10,000

    Request for Waiver

    Initial cash investments in excess of $10,000 and optional cash payments 
in excess of $10,000 per month may be made only pursuant to a written Request 
for Waiver accepted in writing by CRIIMI MAE. A Request for Waiver must be 
received by CRIIMI MAE at its corporate address or via facsimile at (301) 
231-0334 no later than 12:00 p.m. (noon) Eastern time on the third Trading 
Day preceding the relevant Pricing Period. Request for Waiver forms may be 
obtained by calling the Company at (800) 266-0535 and requesting "CRIIMI MAE 
Investor Services." It is solely within CRIIMI MAE's discretion as to whether 
any such approval for initial cash investments in excess of $10,000 or 
optional cash payments in excess of $10,000 will be granted. In deciding 
whether to approve a Request for Waiver, CRIIMI MAE will consider relevant 
factors including, but not limited to, whether the Plan is then acquiring 
newly issued or treasury shares directly from the Company or acquiring Common 
Shares from third parties in the open market or in privately negotiated 
transactions, the Company's need for additional funds, the attractiveness of 
obtaining such additional funds through the sale of Common Shares as compared 
to other sources of funds, the purchase price likely to apply to any sale of 
Common Shares under the Plan, the participant submitting the request, the 
extent and nature of such participant's prior participation in the Plan, the 
number of Common Shares held by such participant and the aggregate amount of 
cash investments for which Requests for Waiver have been submitted by all 
participants. If such requests are submitted for any Investment Date for an 
aggregate amount in excess of the amount CRIIMI MAE is then willing to 
accept, CRIIMI MAE may honor such requests in order of receipt, pro rata or 
by any other method that CRIIMI MAE determines in its sole discretion to be 
appropriate.

    The Company anticipates that it will respond to each Request for Waiver 
by the close of business (5:00 p.m. Eastern time) on the second Trading Day 
preceding the relevant Pricing Period. GOOD FUNDS ON ALL APPROVED REQUESTS 
FOR WAIVER MUST BE RECEIVED BY THE AGENT NOT LATER THAN 12:00 P.M. (NOON) 
EASTERN TIME ON THE TRADING DAY IMMEDIATELY PRECEDING THE COMMENCEMENT OF THE 
RELEVANT PRICING PERIOD IN ORDER FOR SUCH FUNDS TO BE INVESTED ON THE 
RELEVANT INVESTMENT DATE. A participant who has delivered an optional cash 
payment in excess of $10,000 or an initial cash investment in excess of 
$10,000 to the Agent may request the return of such optional cash payment or 
initial cash payment at any time prior to the second Trading Day immediately 
preceding the commencement of the relevant Pricing Period.

    The Agent will establish an escrow account for the deposit of optional 
cash payments that exceed $10,000 and initial cash investments that exceed 
$10,000 pending their investment in Common Shares.  Interest that accrues on 
funds deposited in the escrow account pending their investment on the 
Investment Date will be paid to CRIIMI MAE.

    See "--Plan of Distribution; Expenses" below; also see Schedule A for a 
list of important dates applicable to the Request for Waiver.

    Purchase Price

    Common Shares purchased in connection with approved Requests for Waiver 
in open market purchases or 

                                          14
<PAGE>

directly from the Company will be acquired on the Investment Date at a price 
to participants, computed to four decimal places, obtained by (i) averaging 
the daily high and low sales price of the Common Shares on the New York Stock 
Exchange Composite Tape on the Trading Days during the related Pricing Period 
on which the Threshold Price, if any, is satisfied and (ii) subtracting from 
such average the Waiver Discount, if any, applicable to such Common Shares. 
See "--Waiver Discount and Threshold Price" below. Only Common Shares 
purchased with optional cash payments that exceed $10,000 (pursuant to an 
approved Request for Waiver) will receive the Waiver Discount, if any. The 
purchase price to participants of Common Shares purchased with initial cash 
investments that exceed $10,000 will not be reduced by the Waiver Discount.

    Waiver Discount and Threshold Price

    Each month, at least three Trading Days prior to the first day of the 
Pricing Period, the Company may establish a Waiver Discount applicable to 
optional cash payments exceeding $10,000. The Waiver Discount, which may vary 
each month from 0% to 5%, will be established in the Company's sole 
discretion after a review of current market conditions, the level of 
participation in the Plan and current and projected capital needs of the 
Company. The Waiver Discount will apply both to Common Shares purchased 
directly from the Company and Common Shares acquired in open market purchases 
or in negotiated transactions.

    Notwithstanding anything contained herein to the contrary, CRIIMI MAE may 
establish for each Pricing Period a Threshold Price applicable to the 
purchase of newly issued Common Shares purchased through optional cash 
payments and initial cash investments. This Threshold Price, if any, will be 
established by the Company, in its sole discretion, at least three Trading 
Days prior to the first day of the Pricing Period based upon a review of 
current market conditions and other relevant factors. The Threshold Price 
will be a stated dollar amount that the average of the high and low sales 
price of the Common Shares on the New York Stock Exchange Composite Tape for 
a Trading Day of the Pricing Period must equal or exceed in order to be 
included in the calculation of the purchase price for newly issued Common 
Shares acquired from the Company. In the event that such Threshold Price is 
not satisfied for a Trading Day of the Pricing Period, then such Trading Day 
and the trading prices of the Common Shares for that day will be excluded 
from (i) the Pricing Period and (ii) the determination of the purchase price 
of the Common Shares for all optional cash payments and initial cash 
investments. Thus, for example, if the Threshold Price is not satisfied for 
three of the ten Trading Days, then the purchase price of the Common Shares 
will be based upon the remaining seven Trading Days for which the Threshold 
Price was satisfied.

    Each Trading Day of a Pricing Period for which the Threshold Price is not 
satisfied will cause the return of a portion of any optional cash payments 
made pursuant to Requests for Waiver approved by the Company. The returned 
amount will equal one-tenth of such optional cash payments for each Trading 
Day that the Threshold Price is not satisfied. Thus, for example, if the 
Threshold Price is not satisfied for three Trading Days, then 3/10 (i.e., 
30%) of such optional cash payments will be returned without interest.

    The Threshold Price applies to all optional cash payments and initial 
cash investments. The return procedure discussed above applies only to 
optional cash payments made pursuant to Requests for Waiver approved by the 
Company and not to the reinvestment of dividends, optional cash payments that 
do not exceed $10,000 or initial cash investments.

    Participants may obtain the applicable Waiver Discount and Threshold 
Price by telephoning the Company at (800) 266-0535 and requesting "CRIIMI MAE 
Investor Services."

    Any person who acquires Common Shares through the Plan and resells them 
shortly before or after acquiring them may be considered to be an underwriter 
within the meaning of the Securities Act. The Company expects that certain 
persons will acquire Common Shares pursuant to a Request for Waiver and 
resell such Common Shares in order to obtain the financial benefit of any 
Waiver Discount then being offered under the Plan. The Company has no 
arrangements or understandings, informal or formal, with any person relating 
to a distribution of Common Shares to 

                                          15
<PAGE>

be received pursuant to the Plan.

Investment Date

    The Plan's "Investment Date'' for all optional cash payments and initial 
cash investments, including cash investments exceeding $10,000, is the 
eleventh Trading Day after the commencement of the Pricing Period each month. 
 See Schedule A for a list of Investment Dates and associated optional cash 
payment and initial cash investment due dates and Pricing Periods.

Ways to Make Investments

    Personal Check or Money Order

    Optional cash payments that do not exceed $10,000 and initial cash 
investments that do not exceed $10,000 may be made by personal check or money 
order payable in U.S. dollars to "Registrar and Transfer Company." Optional 
cash payments mailed to the Agent should include the Optional Cash Payment 
Form attached to the quarterly statement of account sent to participants or 
available upon request from the Agent or CRIIMI MAE.

    Automatic Investment from a Bank Account

    Participants may also make optional cash payments by arranging to have 
their bank checking accounts debited directly on a monthly basis to have 
Common Shares purchased through the Plan. To initiate direct debiting, a 
participant must complete the "Automatic Cash Investment" portion of the 
Enrollment Form. Debits to participants' accounts will be processed on or 
about the fifteenth day of each month. The minimum monthly account debit is 
$100 and the maximum is $10,000. Participants will not pay any fee in 
connection with optional cash payments made by direct debit. Cash 
contributions may not be accepted by the Agent if a participant imposes any 
restrictions with respect to the number of Common Shares to be purchased, the 
price at which the Common Shares are to be purchased or the timing of the 
purchase.

    To initiate automatic monthly deductions, the participant must provide 
written authorization to the Agent together with a voided blank check for the 
account from which funds are to be drawn. The written request for automatic 
monthly deduction will be processed and will become effective as promptly as 
practicable.

    Participants may change or terminate their automatic monthly deduction 
election by providing new written instructions to the Agent. To be effective 
with respect to a particular month, however, the new instructions must be 
received by the Agent prior to the last Trading Day of the preceding calendar 
month.

    Cashiers Check or Wire (for optional cash payments exceeding $10,000 and
    initial cash investments exceeding $10,000)

    Optional cash payments exceeding $10,000 and initial cash investments 
exceeding $10,000 must be made by cashiers check payable to "Registrar and 
Transfer Company" or by wire transfer, or by such other method that is 
expressly approved by CRIIMI MAE on the Request for Waiver Form with respect 
to such optional cash payment or initial cash investment.

Sale of Common Shares

    Participants may elect to sell Common Shares held in their Plan accounts 
through the Plan.  Participants who wish to sell Common Shares through the 
Plan should request the Agent to sell any number of whole Common Shares held 
in their Plan accounts by giving written instruction to the Agent. The Agent 
will sell Common Shares on the open market through a registered broker-dealer 
as soon as practicable, except where and to the extent necessary under any 

                                          16
<PAGE>

applicable federal securities laws or other government or stock exchange 
regulations. Participants will generally be unable to terminate the sale 
after submitting the request. The Company will have no influence over sales 
of Common Shares on behalf of participants in the Plan. Participants will 
receive the proceeds, less an administrative charge of $10.00 and applicable 
brokerage fees and commissions, if any, and any transfer taxes. Net proceeds 
of Common Shares sold through the Plan will be paid to participants normally 
by check upon settlement of trade. A participant that wishes to sell Common 
Shares held in the Plan other than through the Plan may request that the 
Agent deliver a certificate for such Common Shares to the participant, which 
the participant may then sell through his or her registered broker-dealer.

    If instructions for the sale of Common Shares are received on or after an 
ex-dividend date but before the related dividend payment date, the sale will 
be processed as described above and a separate check for the dividend will be 
mailed following the dividend payment date. A request to sell all Common 
Shares held in a participant's account will be treated as a withdrawal from 
the Plan (see "--Withdrawal" below).

Share Safekeeping

    At the time of enrollment in the Plan, or at any later time, participants 
may use the Plan's share safekeeping service to deposit any Common Share 
certificates in their possession with the Agent. Participants will not be 
charged a fee for this service. Common Shares deposited will be transferred 
into the name of the Agent or its nominee and credited to the participant's 
account under the Plan.

    By using the Plan's share safekeeping service, participants no longer 
bear the risk associated with loss, theft or destruction of stock 
certificates. Also, because Common Shares deposited with the Agent are 
treated in the same manner as Common Shares purchased through the Plan, they 
may be transferred or sold through the Plan in a convenient and efficient 
manner.  See "--Sale of Common Shares" above and "--Withdrawal" and 
"--Gift/Transfer of Common Shares Within the Plan" below.

    Participants who wish to deposit their Common Share certificates with the
Agent must complete and return to the Agent, by registered, insured mail, the
Common Share certificates to be deposited, along with a properly completed
Enrollment Form, if applicable. The certificates should not be endorsed.

Gift/Transfer of Common Shares Within the Plan

    If a participant wishes to transfer the ownership of all or part of the 
Common Shares held in the participant's Plan account to a Plan account for 
another person, whether by gift, private sale or otherwise, the participant 
may effect such transfer by written request to the Agent, together with an 
executed stock assignment (stock power) and a check for $5.00 payable to 
"Registrar and Transfer Company," to the Agent. Requests for transfer are 
subject to the same requirements as for the transfer of Common Share 
certificates, including requirements of a signature guarantee on the stock 
assignment.

    Common Shares so transferred will continue to be held by the Agent under 
the Plan. An account will be opened in the name of the transferee, if he or 
she is not already a participant, and such transferee will automatically be 
enrolled in the Plan. If the transferee is not already a registered holder of 
Common Shares or a Plan participant, the donor may make a reinvestment 
election for the transferee at the time of the gift. The transferee may 
change the reinvestment election after the gift has been made as described 
under "--Reinvestment of Cash Dividends" above.  

    The transferee will receive a statement showing the number of Common 
Shares transferred to and held in the transferee's Plan account.

Reports to Participants

    As soon as practicable after each purchase of Common Shares by the Agent 
for the participant's account, a 

                                          17
<PAGE>

confirmation of the transaction will be mailed to the participant by the 
Agent. In addition, a statement of account will be mailed by the Agent to the 
participant quarterly. These confirmation receipts and quarterly statements 
are the participant's continuing record of current activity and should be 
retained for tax purposes. In addition, each participant will receive all 
communications sent to other holders of the Company's Common Shares, 
including any annual and quarterly reports to holders of the Company's Common 
Shares, proxy statements and dividend income information for tax reporting 
purposes. Participants should be aware that it is important to retain all 
statements received as there could be a fee incurred when requesting the 
Agent to supply past history.

    All notices, statements and reports from the Agent to a participant will 
be addressed to the participant at his or her latest address of record with 
the Agent. Therefore, participants must promptly notify the Agent of any 
change of address. To be effective with respect to mailings of dividend 
checks and quarterly statements and reports for a particular quarter, address 
changes must be received by the Agent prior to the record date for that 
quarter's dividend.

Certificates for Common Shares

    Common Shares purchased and held under the Plan will be held in 
safekeeping by the Agent in its name or the name of its nominee. The number 
of Common Shares (including fractional shares) held for each participant will 
be shown on each statement of account. Participants may obtain a new 
certificate for all or some of the whole Common Shares held in their Plan 
accounts upon written request to the Agent. Any remaining whole or fractional 
Plan Shares will continue to be held by the Agent. Withdrawal of Common 
Shares in the form of a certificate in no way affects dividend reinvestment. 
See "--Reinvestment of Cash Dividends" above.

    Except as described above under "Gift/Transfer of Common Shares Within 
the Plan," Common Shares held by the Agent for a participant's Plan account 
may not be pledged or assigned. A participant who wishes to pledge or assign 
any such Common Shares must request that a certificate for such Common Shares 
be issued in the participant's name.

Plan of Distribution; Expenses

    Except to the extent the Agent effects purchases of Common Shares in open 
market transactions through a registered broker-dealer or in privately 
negotiated transactions negotiated by CRIIMI MAE, the Agent will acquire 
Common Shares directly from the Company for the Plan. The Company may sell 
Common Shares to owners of Common Shares (including brokers or dealers) who, 
in connection with any resales of such Common Shares, may be deemed to be 
underwriters. Such Common Shares, including Common Shares acquired pursuant 
to Requests for Waiver approved with respect to the optional cash payment and 
initial cash investment features of the Plan, may be resold in market 
transactions (including coverage of short positions) on any national 
securities exchange on which Common Shares trade or in privately negotiated 
transactions. The Common Shares are currently listed on the NYSE. 

    Under certain circumstances, it is expected that a portion of the Common 
Shares available for issuance under the Plan will be issued pursuant to such 
Requests for Waiver. The difference between the price such owners pay to the 
Company for Common Shares acquired under the Plan, after deduction of the 
applicable discount from the market price (in the case of optional cash 
payments that exceed $10,000), and the price at which such Common Shares are 
resold, may be deemed to constitute underwriting commissions received by such 
owners in connection with such transactions.

    Subject to the availability of Common Shares registered for issuance 
under the Plan, there is no total maximum number of Common Shares that can be 
issued pursuant to the reinvestment of dividends. From time to time, 
financial intermediaries may engage in positioning transactions in order to 
benefit from the discount from the market price of Common Shares acquired 
through the reinvestment of dividends under the Plan.

    Common Shares purchased for a participant with respect to a particular 
Investment Date will be credited to the participant's account at the weighted 
average price per share of all Common Shares purchased with respect to that 
Investment Date (less any applicable discount). Participants have no control 
over the terms and conditions, including 

                                          18
<PAGE>


price and delivery, pursuant to which Common Shares are purchased or whether 
Common Shares are purchased in the open market through registered 
broker-dealers, in private transactions negotiated by the Company or directly 
from the Company.

    The Company will pay the costs of administering the Plan, including 
charges by the Agent for bank services on each dividend reinvestment. 
Participants will not pay brokerage commissions on Common Shares purchased 
directly from the Company. In addition, the Company will pay all brokerage 
commissions related to purchases of Common Shares in the open market effected 
through registered broker-dealers. The Company will also pay any processing 
fees associated with the direct debit feature of the Plan. The Agent may 
charge a participant for additional services not provided under the Plan or 
where specified charges are indicated. Certain expenses will be incurred by 
the participant if the participant requests that Common Shares be sold. 
Brokers or nominees who participate on behalf of Beneficial Owners for whom 
they are holding Common Shares may charge such beneficial owners fees in 
connection with such participation, for which neither the Agent nor the 
Company will be responsible.
                                           
Withdrawal

    A participant may withdraw from the Plan at any time by giving written 
instructions to the Agent. Upon a participant's withdrawal from the Plan, a 
certificate for the whole Common Shares held in the Plan for the participant 
will be issued. Alternatively, a participant may specify in the withdrawal 
notice that all (but not less than all) whole Plan Shares be sold. The Agent 
will effect the sale through a registered broker-dealer on the open market as 
soon as practicable after receipt of the withdrawal notice (see "--Source and 
Price of Common Shares" above), and the participant will receive a check for 
the proceeds, less an administrative charge of $10.00 and applicable 
brokerage fees and commissions, if any, and any transfer taxes.

    Whether whole Plan Shares are withdrawn or sold, participants terminating 
their participation in the Plan will receive a check for the cash value of 
any fractional Common Shares held in their Plan accounts. Fractions of Common 
Shares will be valued at the same effective price as whole Common Shares sold.

    If notice of withdrawal is received on or after an ex-dividend date but 
before the related dividend payment date, the withdrawal will be processed as 
described above and a separate check for the dividend will be mailed 
following the dividend payment date.

    After participation in the Plan has been terminated, no further 
investments may be made without re-enrolling in the Plan.

Miscellaneous 

    Stock Split, Stock Dividend or Rights Offering

    Any dividends in Common Shares or split shares distributed by the Company 
on Common Shares held in the Plan will be added to the participant's account. 
Common Share dividends or split shares distributed on certificated Common 
Shares will be credited to the participant's account, unless otherwise 
instructed.

    In the event of a rights offering, the participant will receive rights 
based upon the total number of whole Common Shares owned, that is, the total 
number of Plan Shares and certificated Common Shares standing in the 
participant's name.

    Voting of Common Shares Held in the Plan

    Whole and fractional Common Shares held in a Plan account may be voted in 
person or by the proxy sent to the participant.

                                          19
<PAGE>

    Limitation of Liability

    Neither the Company nor the Agent (nor any of their respective agents, 
representatives, employees, officers, directors or subcontractors) will be 
liable in administering the Plan for any act done in good faith nor for any 
good faith omission to act, including, without limitation, any claim of 
liability arising with respect to the prices or times at which Common Shares 
are purchased or sold for participants, or any change in the market value of 
Common Shares, or from failure to terminate a participant's account upon a 
participant's death. The foregoing does not represent a waiver of any rights 
a participant may have under applicable securities laws.

    Change or Termination of the Plan

    The Company, in its sole discretion, may suspend, modify or terminate the 
Plan at any time in whole, in part, or in respect of participants in one or 
more jurisdictions. Written notice of such suspension, modification or 
termination will be sent to all affected participants at least ten days prior 
to such action. No such event will affect any Common Shares then credited to 
a participant's account. Upon any whole or partial termination of the Plan by 
the Company, certificates for whole Common Shares held in an affected 
participant's account under the Plan will be issued to the participant and a 
cash payment will be made for any fractional Common Share held in his or her 
Plan account. Any change in the Waiver Discount made by the Company shall not 
constitute a modification of the Plan requiring notice to participants.

    Termination of a Participant 

    The Company may terminate any participant's participation in the Plan for 
any reason (including, without limitation, the attempted circumvention by a 
participant of the $10,000 monthly maximum for cash purchases through the 
accumulation of Plan accounts over which they have control) after written 
notice in advance mailed to such participant at the address appearing on the 
Agent's records. A participant whose participation in the Plan has been 
terminated will receive certificates for whole Common Shares held in his or 
her account and a check for the cash value of any fractional Common Shares 
held in his or her Plan account.

               CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
                                           
    The following summary of certain U.S. federal income and estate tax 
consequences of the reinvestment of dividends pursuant to the Plan is based 
on current law, is for general information only and is not tax advice. This 
discussion does not purport to deal with all aspects of taxation that may be 
relevant to particular investors in light of their personal investment 
circumstances, or certain types of investors (including insurance companies, 
tax-exempt organizations, financial institutions and broker-dealers) subject 
to special treatment under the federal income tax laws.  Those considering 
participation in the Plan are urged to consult with their own tax advisors 
regarding the specific tax consequences (including the federal, state, local 
and foreign tax consequences) that may result from their participation in the 
Plan and of potential changes in applicable tax laws.  For purposes of this 
discussion, a "U.S. Holder" is a participant or Beneficial Owner that is (i) 
a citizen or resident of the United States, (ii) a corporation or partnership 
created or organized in the United States or under the laws of the United 
States or of any state, (iii) an estate whose income is includable in gross 
income for United States federal income tax purposes regardless of its source 
or (iv) a trust if a United States court is able to exercise primary 
supervision over the administration of the trust and one or more United 
States persons have the authority to control all substantial decisions of the 
trust. Notwithstanding the preceding sentence, to the extent provided in the 
regulations promulgated by the Treasury Department, certain trusts in 
existence on August 20, 1996 and treated as United States persons prior to 
such date that elect to continue to be so treated also shall be considered 
United States persons. A "Non-U.S. Holder" is any participant or Beneficial 
Owner that is not a U.S. Holder. For purposes of the withholding tax on 
dividends discussed below, a non-resident fiduciary of an estate or trust 
will be considered a Non-U.S. Holder. 

U.S. Holders

                                          20
<PAGE>

    Dividend Reinvestment

    The reinvestment of dividends does not relieve the U.S. Holder of any 
federal income tax which may be payable on such dividends. Dividends paid 
with respect to Common Shares that are reinvested in Common Shares purchased 
directly from CRIIMI MAE will be treated for federal income tax purposes as 
having been received by the U.S. Holder in the form of a taxable stock 
dividend. Accordingly, an amount equal to the fair market value on the date 
of purchase of Common Shares acquired with reinvested dividends will be 
treated as a dividend to the extent that CRIIMI MAE has current or 
accumulated earnings and profits for federal income tax purposes. Dividends 
paid with respect to Common Shares that are reinvested in Common Shares 
purchased on the open market will be treated for federal income tax purposes 
as having been received by the U.S. Holder in the form of a cash dividend. 
Accordingly, the actual amount of cash provided by CRIIMI MAE that is used to 
purchase the Common Shares on the open market (whether such cash is a payment 
of stated dividends or an additional amount paid by CRIIMI MAE to allow the 
Common Shares to be provided to the U.S. Holders at 98% of the average 
closing sales price), plus (as discussed in more detail below) the amount of 
any brokerage commissions paid by CRIIMI MAE with respect to the Common 
Shares, will be treated as a dividend for federal income tax purposes to the 
extent that CRIIMI MAE has current or accumulated earnings and profits for 
federal income tax purposes. U.S. Holders having made optional cash payments 
will be deemed to have received a dividend for federal income tax purposes 
equal to the excess of the fair market value of the Common Shares purchased 
with optional cash payments over the amount of such optional cash payments.  

    Dividends in excess of current and accumulated earnings and profits, if 
any, would not be taxable to a U.S. Holder to the extent that such dividends 
do not exceed the adjusted basis of the U.S. Holder's Common Shares. To the 
extent such dividends exceed the adjusted basis of a U.S. Holder's Common 
Shares, they would be includable in income as capital gain. In addition, in 
the event that the Company designates a part or all of the amount so 
distributed as a capital gain dividend, such amount would be treated by the 
U.S. Holder as long-term capital gain. A Form 1099-DIV mailed to U.S. Holders 
at year-end will show total income and the amount of any capital gain 
dividend.

    The Internal Revenue Service ("IRS") has ruled in private letter rulings 
that brokerage commissions paid by a corporation on behalf of participants in 
a dividend reinvestment plan (i.e., in the case of open market purchases of 
Common Shares) were to be treated as constructive dividends to the 
participants. Such constructive dividends were subject to income tax in the 
same manner as dividends and were includable in the participants' cost basis 
of the Common Shares purchased. Accordingly, if the Company pays brokerage 
commissions with respect to any open market purchases made by the Agent, the 
Company intends to take the position that participants will have received 
their proportionate amount of such commissions as additional dividends. In 
addition, consistent with the foregoing, CRIIMI MAE intends to reflect any 
discount for purchases of Common Shares under the Plan as constructive 
dividends to participants. The information return sent by the Agent to you 
and the IRS at the end of the year will show the amount of such dividends 
paid to you. While the matter is not free from doubt, CRIIMI MAE intends to 
take the position that administrative expenses of the Plan paid by CRIIMI MAE 
are not constructive dividends to participants.

    The tax basis of Common Shares acquired directly from CRIIMI MAE pursuant 
to the reinvestment of dividends under the Plan will be equal to the fair 
market value of the Common Shares on the applicable date of purchase. The tax 
basis of Common Shares acquired on the open market pursuant to the 
reinvestment of dividends under the Plan will be equal to the actual purchase 
price of the Common Shares provided to U.S. Holders pursuant to the Plan plus 
the U.S. Holder's share of brokerage commissions, if any. The holding period 
of Common Shares acquired under the Plan will begin on the day following the 
date as of which the Common Shares were purchased for the U.S. Holder's 
account.

    A U.S. Holder will not realize any taxable income when the U.S. Holder 
receives certificates for Common Shares credited to the U.S. Holder's 
account, either upon the U.S. Holder's request for such certificates or upon 
withdrawal from or termination of the Plan. However, a U.S. Holder may 
recognize gain or loss when Common Shares acquired under the Plan are sold or 
exchanged or when a U.S. Holder receives cash for fractional Common Shares. 
The amount of such gain or loss will be the difference between the amount 
received in such sale or exchange for the U.S. Holder's Common Shares and the 
tax basis thereof.

                                          21
<PAGE>

    The IRS has ruled in connection with similar plans that a dividend 
reinvestment plan will not adversely affect the qualification of a REIT for 
federal income tax purposes. In addition, REITs should be able to include 
amounts deemed distributed as dividends under such a plan for purposes of its 
dividends-paid deduction.

    Optional Purchases

    The IRS has indicated in somewhat similar situations that a participant 
who makes an optional cash payment for the purchase of Common Shares under 
the Plan will be treated as having received a distribution equal to the 
excess of the fair market value on the Investment Date of such Common Shares 
over the amount of the optional cash payment made by the participant.  In 
addition, if Common Shares are acquired by the Agent in an open-market 
transaction, the IRS may assert that a participant has received an additional 
distribution equal to a pro rata share of any commissions or fees paid by the 
Company on behalf of the participant.  

    The taxation of such a distribution is not entirely clear.  Participants 
should be aware that the Company will treat the entire amount of any deemed 
distribution, for tax reporting purposes, as a distribution taxable as a 
dividend to the extent of the Company's current or accumulated earnings and 
profits.  Accordingly, a participant's tax basis in his or her Common Shares 
acquired through optional cash payments under the Plan will generally equal 
the total amount of the optional cash payments plus any distribution a 
participant is deemed to have received (as described above).  A participant's 
holding period for Common Shares purchased under the Plan generally will 
begin on the day following the date on which Common Shares are credited to 
the participant's account.    

    It is possible, however, that all or a portion of such deemed 
distribution should be treated as a tax-free return of capital or not treated 
as a taxable distribution.  Participants are encouraged to consult their own 
tax counsel in this regard.

Non-U.S. Holders

    In general, distributions to a Non-U.S. Holder of Common Shares which are 
not attributable to gain from the sale or exchange of United States real 
property interests and are not designated by the Company as capital gain 
dividends will be treated as dividends of ordinary income (to the extent of 
earnings and profits) for U.S. federal income tax purposes. Such 
distributions ordinarily will be subject to withholding of U.S. federal 
income tax at a 30% rate, unless such rate is reduced by an applicable income 
tax treaty. Dividends that are effectively connected with such Non-U.S. 
Holder's conduct of a trade or business in the United States or, if a tax 
treaty applies, attributable to a permanent establishment in the United 
States ("U.S. trade or business income") generally are subject to U.S. 
federal income tax at regular rates (and, in the case of a Non-U.S. Holder 
that is a corporation, under certain circumstances may be subject to an 
additional "branch profits tax" at a 30% rate or such lower rate as may be 
applicable under an income tax treaty), but are not generally subject to the 
30% withholding tax if the Non-U.S. Holder files the appropriate form with 
the payer. If you are a Non-U.S. Holder whose dividends are subject to United 
States income tax withholding, the appropriate amount will be withheld and 
the remaining balance will be used to purchase additional Common Shares.

    Distributions by CRIIMI MAE which are not dividends out of earnings and 
profits (as determined for U.S. federal income tax purposes) should not be 
subject to U.S. withholding tax. Such distributions are treated first as a 
tax-free return of capital to the Non-U.S. Holder and reduce the tax basis of 
the Non-U.S. Holder's Common Shares by the amount of such distribution (but 
not below zero).  Distributions in excess of the Non-U.S. Holder's tax basis 
are taxable as a sale or exchange of Common Shares. If it cannot be 
determined at the time a distribution is made whether or not such 
distribution will be in excess of current and accumulated earnings and 
profits, the entire amount of the distribution will be subject to withholding 
at the rate applicable to dividends. However, the Non-U.S. Holder may seek a 
refund of such amounts from the IRS if it is subsequently determined that 
such distribution was, in fact, in excess of current and accumulated earnings 
and profits of CRIIMI MAE. CRIIMI MAE does not expect to pay dividends in 
excess of current and accumulated earnings and profits. 

                                          22
<PAGE>

    Under the Foreign Investment in Real Property Tax Act of 1980 ("FIRPTA"), 
for as long as the Company qualifies as a REIT, a distribution made by CRIIMI 
MAE to a Non-U.S. Holder that is attributable to gains from the sale or 
exchange of U.S. real property interests generally will be taxable as if the 
distributions were gains "effectively connected" with a U.S. trade or 
business. Therefore, in such circumstances, Non-U.S. Holders generally will 
be taxed at the capital gain rates applicable to U.S. Holders (subject to 
applicable alternative minimum tax and a special alternative minimum tax in 
the case of nonresident alien individuals). Distributions subject to FIRPTA 
also may be subject to a 30% branch profits tax in the hands of a corporate 
Non-U.S. Holder (unless reduced or eliminated by treaty). In addition, the 
Company will be required to withhold U.S. tax equal to 35% of the amount of 
dividends that could have been designated as capital gain dividends, but such 
requirement apparently is limited to the amount of such gain that is 
attributable to the sale or exchange of U.S. real property interests. The 
amount so withheld is creditable against the U.S. federal income tax 
liability of such Non-U.S. Holder and a refund may be available if the amount 
withheld exceeds the U.S. federal income tax liability of the Non-U.S. 
Holder. 

    In order to obtain complete exemption from withholding with respect to 
dividends, a Non-U.S. Holder must provide the Company in a timely manner with 
either (i) an IRS Form 1001 stating that the Non-U.S. Holder is entitled to a 
complete exemption under an applicable treaty, or (ii) if such dividends are 
"effectively connected" income, an IRS Form 4224. In order to obtain a 
partial exemption from withholding with respect to dividends based on a 
treaty, a Non-U.S. Holder must provide CRIIMI MAE in a timely manner with an 
IRS Form 1001, stating that the Non-U.S. Holder is so entitled to such a 
reduced rate on dividends paid. Such forms must be signed by the Non-U.S. 
Holder or the Non-U.S. Holder's agent. A Non-U.S. Holder that is required to 
submit a certification on Form 1001 or 4224 to avoid the imposition of United 
States federal withholding tax with respect to a dividend on Common Shares is 
required to submit such certification to CRIIMI MAE as soon as practicable 
after the Non-U.S. Holder acquires such Common Shares or a beneficial 
interest therein. If the Company does not physically receive such 
certification by the date that is 10 days prior to a dividend payment date, 
the Company may treat such certification as ineffective with respect to any 
payment to such Non-U.S. Holder and may withhold tax from such payment on 
such date. The Non-U.S. Holder will be responsible for ensuring that all IRS 
Forms are properly updated. If an IRS form provided by a Non-U.S. Holder is 
not properly updated, CRIIMI MAE will commence withholding on the dividend 
payment date on or following the date that such form becomes no longer 
current.

    In general, an individual who is a Non-U.S. Holder for U.S. estate tax 
purposes will incur liability for U.S. federal estate tax if the fair market 
value of the property included in such individual's taxable estate for U.S. 
federal estate tax purposes exceeds the statutory threshold amount. For these 
purposes, Common Shares owned or treated as owned by an individual who is a 
Non-U.S. Holder (for U.S. estate tax purposes) at the time of death will be 
included in the individual's taxable estate for U.S. federal estate tax 
purposes, unless an applicable estate tax treaty provides otherwise. 

    On October 6, 1997, the Treasury Department issued final rules with 
respect to withholding tax on income paid to foreign persons and related 
matters (the "New Withholding Regulations").  The New Withholding Regulations 
will generally be effective for payments made after December 31, 1998, 
subject to certain transition rules. Non-U.S. Holders are urged to consult 
with their own tax advisors with respect to the New Withholding Regulations.

Backup Withholding

    If you fail to provide certain federal income tax certifications in the 
manner required by law (such as the taxpayer identification number), 
dividends on and proceeds from the sale of any Common Shares held for your 
account are subject to federal backup withholding, currently at the rate of 
31%. Certain exempt holders of the Company's Common Shares (including most 
corporations) are, however, exempt from the above withholding requirements, 
provided that certain certifications are made.

    Any amounts withheld under the backup withholding rules from a payment to 
a person would be allowed as a refund or a credit against that person's 
United States federal income tax, provided that the required information is 

                                          23
<PAGE>

furnished to the IRS. Furthermore, certain penalties may be imposed by the 
IRS on a Holder who is required to supply information but who does not do so 
in the proper manner.

                                   USE OF PROCEEDS
                                           
    CRIIMI MAE intends to use the net proceeds from the sale of the Common 
Shares offered pursuant to the Plan (i) to acquire or originate mortgage 
assets, primarily Subordinated CMBS, (ii) to sponsor and/or participate in 
collateralized mortgage obligation programs and (iii) for other general 
corporate purposes, including working capital.  Pending their use for the 
foregoing purposes, the net proceeds are expected to be invested in 
short-term, interest-bearing accounts and/or used to pay down debt on a 
temporary basis.

                                    LEGAL MATTERS

    Certain legal matters will be passed upon for CRIIMI MAE by Swidler & 
Berlin, Chartered, Washington, D.C.

                                       EXPERTS

    The financial statements included in CRIIMI MAE's Annual Report on Form 
10-K for the year ended December 31, 1996, incorporated herein by reference, 
have been audited by Arthur Andersen LLP, independent public accountants, as 
indicated in their reports with respect thereto, and have been incorporated 
by reference herein in reliance upon the authority of said firm as experts in 
accounting and auditing in giving said reports. 

                                          24
<PAGE>

                                      Schedule A

                         List of Important Dates for the Plan

    The following list sets forth, for each quarter through the quarter ended 
December 31, 1999, the Dividend Reinvestment Date. 

    Dividend Reinvestment Date
         01/02/98
         04/01/98
         07/01/98
         10/01/98
         01/04/99
         04/01/99
         07/01/99
         10/01/99
         01/03/00                       

    The following list sets forth, for each month through the month ended 
December 31, 1999, (i) the latest date on which the Threshold Price and 
Waiver Discount may be set by the Company, (ii) the date by which initial 
cash investments and optional cash payments must be received by the Agent for 
investment on the Investment Date, (iii) the date that the Pricing Period 
commences and (iv) the Investment Date (i.e., the date on which initial cash 
investments and optional cash payments will be invested in Common Shares).

    Threshold             Initial Cash Investment     Pricing
    Price and Waiver      and Optional Cash           Period        Investment
    Discount Set          Payment due Date            Commences     Date
  
    12/29/97              12/31/97                    01/02/98      01/16/98
    01/28/98              01/30/98                    02/02/98      02/17/98
    02/25/98              02/27/98                    03/02/98      03/16/98
    03/27/98              03/31/98                    04/01/98      04/16/98
    04/28/98              04/30/98                    05/01/98      05/15/98
    05/27/98              05/29/98                    06/01/98      06/15/98
    06/26/98              06/30/98                    07/01/98      07/16/98
    07/29/98              07/31/98                    08/03/98      08/17/98
    08/27/98              08/31/98                    09/01/98      09/16/98
    09/28/98              09/30/98                    10/01/98      10/16/98
    10/28/98              10/30/98                    11/02/98      11/17/98
    11/25/98              11/30/98                    12/01/98      12/15/98
    12/29/98              12/31/98                    01/04/99      01/19/99
    01/27/99              01/29/99                    02/01/99      02/16/99
    02/24/99              02/26/99                    03/01/99      03/15/99
    03/29/99              03/31/99                    04/01/99      04/16/99
    04/28/99              04/30/99                    05/03/99      05/17/99
    05/26/99              05/28/99                    06/01/99      06/15/99
    06/28/99              06/30/99                    07/01/99      07/16/99
    07/28/99              07/30/99                    08/02/99      08/16/99
    08/27/99              08/31/99                    09/01/99      09/16/99
    09/28/99              09/30/99                    10/01/99      10/18/99
    10/27/99              10/29/99                    11/01/99      11/16/99
    11/24/99              11/30/99                    12/01/99      12/15/99 

<PAGE>

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

    No dealer, salesperson or other person is authorized in connection with 
any offering made hereby to give any information or to make any 
representation other than those contained or incorporated by reference in 
this Prospectus and, if given or made, such information or representation 
must not be relied upon as having been authorized.  This Prospectus does not 
constitute an offer to sell or a solicitation of an offer to buy any security 
other than the securities offered hereby, nor does it constitute an offer to 
sell or a solicitation of any offer to buy any of the securities offered 
hereby to any person in any jurisdiction in which it is unlawful to make such 
an offer or solicitation.  Neither the delivery of this Prospectus nor any 
sale made hereunder shall, under any circumstances, create any implication 
that the information contained herein is correct as of any date subsequent to 
the date hereof.

                                  TABLE OF CONTENTS

                                                                            Page

Available Information..........................................................2
Incorporation of Certain Documents by Reference................................2
Summary of the Plan............................................................3
CRIIMI MAE.....................................................................6
CRIIMI MAE Inc. Dividend Reinvestment and 
    Stock Purchase Pla.........................................................6
Certain United States Federal Income Tax Considerations.......................20
Use of Proceeds...............................................................24
Legal Matters.................................................................24
Experts.......................................................................24
List of Important Dates...............................................Schedule A





                                Dividend Reinvestment
                               and Stock Purchase Plan




                                   CRIIMI MAE Inc.





                               5,000,000 Common Shares



                                 ____________________

                                      PROSPECTUS
                                 ____________________




                                  December __, 1997

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
 
<PAGE>


                                       PART II

                        INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.  Other Expenses of Issuance and Dividend

     All of the expenses set forth below, except the SEC registration fee, are
estimated.

     SEC registration fee                                   $19,078
     New York Stock Exchange listing fee
     Printing and engraving expenses                          7,000
     Accounting fees and expenses
     Legal fees and expenses                                 25,000
     Blue Sky fees and expenses (including legal fees)
     Agent fees
     Miscellaneous
                                                                 ---
          Total                                                    $
                                                            --------
                                                            --------
- -----------
     All of the above are estimated, except the SEC registration fee.

Item 15.  Indemnification of Directors and Officers

     Under Maryland law, a corporation formed under Maryland law is permitted 
to limit, by provisions in its articles of incorporation, the liability of 
its directors and officers to the corporation or its stockholders for money 
damages except for (i) actual receipt of an improper benefit or profit in 
money, property or services or (ii) active and deliberate dishonesty 
established by a final judgment as being material to the cause of action. 
CRIIMI MAE's Articles of Incorporation include such a provision which limits 
such liability to the fullest extent permitted by Maryland law.

     CRIIMI MAE's Bylaws provide that CRIIMI MAE shall indemnify its 
directors and officers, and may indemnify other persons who may be 
indemnified, to the fullest extent permitted by Maryland law against any 
liability and related expenses (including attorneys' fees) incurred in 
conjunction with any proceeding or threatened proceeding in which any of them 
may be involved, or threatened to be involved, as a party or otherwise, 
arising out of or incidental to CRIIMI MAE's business.  CRIIMI MAE has 
purchased and maintains liability insurance against liabilities that may be 
asserted against such persons in connection with CRIIMI MAE, whether or not 
indemnification against such liabilities would be permitted under the 
provisions of CRIIMI MAE's Articles of Incorporation.

     Section 2-418 of the General Corporation Law of the State of Maryland 
provides, together with the Bylaws described above, for the indemnification 
of directors, officers and other corporate agents in terms sufficiently broad 
to indemnify such persons, under certain circumstances, for liabilities 
(including reimbursements of expenses incurred) arising under the Securities 
Act. 

<PAGE>

Item 16.  Exhibits

     (a) Exhibits.

     Exhibit
     Number              Description

     *4.1 --Articles of Incorporation, as amended, of CRIIMI MAE Inc.
     *4.2 --Bylaws, as amended, of CRIIMI MAE Inc.
     *4.6 --Form of specimen certificate representing Common Shares
        5 --Opinion regarding validity of securities being registered
        8 --Tax Opinion 
     23.1 --Consent of Arthur Andersen LLP
     23.2 --Consent of Swidler & Berlin, Chartered (included in Exhibit 5)
     24.1 --Power of Attorney (included on signature page)
     99.1 --Form of Enrollment Form

- -----------
     * Incorporated herein by reference to CRIIMI MAE's Registration Statement
          on Form S-3 (File No. 33-50679), as amended. 

<PAGE>

Item 17.  Undertakings

     The undersigned registrant hereby undertakes: (1) to file, during any 
period in which offers or sales are being made, a post-effective amendment to 
this registration statement to include any material information with respect 
to the plan of distribution not previously disclosed in the registration 
statement or any material change to such information in the registration 
statement; (2) for the purpose of determining any liability under the 
Securities Act, each post-effective amendment that contains a form of 
prospectus shall be deemed to be a new registration statement relating to the 
securities offered therein, and the offering of such securities at that time 
shall be deemed to be the initial bona fide offering thereof; and (3) to 
remove from registration by means of a post-effective amendment any of the 
securities being registered which remain unsold at the termination of the 
offering.

     The undersigned registrant also hereby undertakes that, for purposes of 
determining any liability under the Securities Act of 1933, each filing of 
the registrant's annual report pursuant to Section 13(a) or Section 15(d) of 
the Securities Exchange Act of 1934 that is incorporated by reference in the 
registration statement shall be deemed to be a new registration statement 
relating to the securities offered therein, and the offering of such 
securities at that time shall be deemed to be the initial bona fide offering 
thereof.

     Insofar as indemnification for liabilities arising under the Securities 
Act of 1933 may be permitted to directors, officers and controlling persons 
of the registrant pursuant to the provisions described in Item 15, or 
otherwise, the registrant has been advised that in the opinion of the 
Securities and Exchange Commission such indemnification is against public 
policy as expressed in the Securities Act of 1933 and is, therefore, 
unenforceable.  If a claim for indemnification against such liabilities 
(other than the payment by the registrant of expenses incurred or paid by a 
director, officer or controlling person of the registrant in the successful 
defense of any action, suit or proceeding) is asserted by such director, 
officer or controlling person in connection with the securities being 
registered, the registrant will, unless in the opinion of its counsel the 
matter has been settled by controlling precedent, submit to a court of 
appropriate jurisdiction the question whether such indemnification by it is 
against public policy as expressed in the Securities Act of 1933 and will be 
governed by the final adjudication of such issue.

 
<PAGE>


                                      SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, the
registrant certifies that it has reasonable grounds to believe that it meets the
requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Rockville, State of Maryland, on the 1st day of
December, 1997.

                                   CRIIMI MAE INC.
                                   By:  /s/      William B. Dockser
                                      -----------------------------------
                                                William B.  Dockser
                                               Chairman of the Board

     KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature 
appears below constitutes and appoints William B. Dockser and H. William 
Willoughby, and each of them severally, as his true and lawful 
attorneys-in-fact and agents, with full power of substitution and 
resubstitution, for him and in his name, place, and stead, in any and all 
capacities, to sign any and all amendments (including post-effective 
amendments) to this Registration Statement, and to file the same, with all 
exhibits thereto, and other documents in connection therewith, with the 
Securities and Exchange Commission, granting unto said attorneys-in-fact and 
agents, full power and authority to do and perform each and every act and 
thing requisite and necessary to be done in connection therewith, as fully to 
all intents and purposes as he or she might or could do in person, hereby 
ratifying and confirming all that said attorneys-in-fact and agents or any of 
them, or of his or her substitute or substitutes, may lawfully do or cause to 
be done by virtue hereof.

     Pursuant to the requirements of the Securities Act of 1933, as amended, 
this registration statement has been signed by the following persons in the 
capacities and on the dates indicated.

<TABLE> 

<S>                           <C>                                     <C>
/s/  William B. Dockser       Chairman of the Board (Principal        December  1, 1997
- ---------------------------   Executive Officer and Director)
     William B. Dockser         

/s/  H. William Willoughby    Director, President and Secretary       December  1, 1997
- ---------------------------
     H. William Willoughby

/s/  Garret G. Carlson*       Director                                December  1, 1997
- ---------------------------
     Garrett G. Carlson

/s/  Larry H. Dale*           Director                                December  1, 1997
- ---------------------------
     Larry H Dale

/s/  G. Richard Dunnells*     Director                                December  1, 1997
- ---------------------------
     G. Richard Dunnells

/s/  Robert J. Merrick*       Director                                December  1, 1997
- ---------------------------
     Robert J. Merrick

/s/  Cynthia O. Azzara        Chief Financial Officer                 December  1, 1997
- ---------------------------   (Principal Financial and 
     Cynthia O. Azzara        Accounting Officer)
</TABLE>

 
<PAGE>

                                    EXHIBIT INDEX

     Exhibit
     Number              Description                                        Page

     *4.1 --Articles of Incorporation, as amended, of CRIIMI MAE Inc.
     *4.2 --Bylaws, as amended, of CRIIMI MAE Inc.
     *4.6 --Form of specimen certificate representing Common Shares
        5 --Opinion regarding validity of securities being registered
        8 --Tax Opinion 
     23.1 --Consent of Arthur Andersen LLP
     23.2 --Consent of Swidler & Berlin, Chartered (included in Exhibit 5)
     24.1 --Power of Attorney
     99.1 --Form of Enrollment Form

- -----------
     * Incorporated herein by reference to CRIIMI MAE's Registration Statement
       on Form S-3 (File No. 33-50679), as amended.  


<PAGE>

                                                                       Exhibit 5


[SWIDLER & BERLIN, CHARTERED LETTERHEAD]


                                   December 1, 1997



The Board of Directors
CRIIMI MAE Inc.
11200 Rockville Pike
Rockville, Maryland

     Re:  Registration Statement on Form S-3

Gentlemen:

     We have acted as counsel to CRIIMI MAE Inc., a Maryland corporation (the 
"Company"), with respect to the Company's Registration Statement on Form S-3 
(the "Registration Statement") filed with the Securities and Exchange 
Commission, in connection with the registration under the Securities Act of 
1933, as amended (the "Securities Act"), of up to five million shares of the 
Company's common stock, par value $.01 per share ("Common Shares"), which 
Common Shares may be sold by the Company from time to time pursuant to the 
CRIIMI MAE Inc. Dividend Reinvestment and Stock Purchase Plan, as set forth 
in the prospectus which forms a part of the Registration Statement.  This 
opinion letter is furnished to you at your request to enable you to fulfill 
the requirements of Item 601(b)(5) of Regulation S-K, 17 C.F.R. ss. 
229.601(b)(5), in connection with the Registration Statement. 

     As counsel to the Company, we have examined the Company's Articles of 
Incorporation, as amended (the "Articles"), and such Company records, 
certificates and other documents and relevant statutes, regulations, 
published rulings and such questions of law as we considered necessary or 
appropriate for the purpose of this opinion. 

     In our examination, we have assumed the authenticity of original 
documents, the accuracy of copies and the genuineness of signatures.  We have 
relied upon the representations and statements of officers and other 
representatives of the Company with respect to the factual determinations 
underlying the legal conclusions set forth herein.  We have not attempted to 
verify independently such representations and statements.

     We assume that the issuance, sale, amount and terms of the Common Shares 
to be offered from time to time will be duly authorized and determined by 
proper action of the Board of Directors of the Company consistent with the 
procedures and terms described in the Registration Statement (each, a "Board 
Action") and in accordance with the Articles and applicable Maryland law. 

     This opinion letter is based as to matters of law solely on (i) the 
General Corporation Law of the State of Maryland and (ii) Maryland contract 
law (but not including any statutes, ordinances, administrative decisions, 
rules or regulations of any political subdivision of Maryland), in each case 
as currently in effect, and we express no opinion herein as to any other 
laws, statutes, ordinances, rules or regulations.

     Based upon, subject to and limited by the foregoing and the other 
qualifications herein, we are of the opinion that, when the Registration 
Statement has become effective under the Securities Act, upon due 
authorization by Board Action, and upon issuance and delivery of such Common 
Shares against payment of valid consideration therefor in accordance with the 
terms of such Board Action, and as contemplated by the Registration 
Statement, such Common Shares will be validly issued, fully paid and 
nonassessable.

     We hereby consent to the filing of this opinion as an exhibit to the 
Registration Statement and to all references to our firm in the Registration 
Statement.  In giving this consent, we do not admit that we come within the 
category of persons whose consent is required under Section 7 of the 
Securities Act or the rules promulgated thereunder.  

     This opinion is rendered solely for your benefit in connection with the 
transactions described above upon the 

<PAGE>

understanding that we are not hereby assuming any professional responsibility 
to any other person.  Except as provided in the preceding paragraph, this 
opinion may not be relied upon by any other person and this opinion may not 
be used, disclosed, quoted, filed with a governmental agency or otherwise 
referred to without our express prior written consent.  The opinions 
expressed in this letter are limited to the matters expressly set forth 
herein, and no other opinions should be inferred beyond the matters expressly 
stated herein.

                         Very truly yours,
                         
                         /s/ Swidler & Berlin, Chartered                   
     

                         SWIDLER & BERLIN, CHARTERED
 


<PAGE>

                                                                       Exhibit 8

[SWIDLER & BERLIN, CHARTERED LETTERHEAD]


                                   December 1, 1997

CRIIMI MAE Inc.
The CRI Building
11200 Rockville Pike
Rockville, MD  20852

          RE:     Sale of Securities Pursuant to Shelf Registration Statement

Gentlemen:

     We have acted as counsel to CRIIMI MAE Inc., a Maryland corporation (the 
"Company"), with respect to the Company's Registration Statement on Form S-3 
(the "Registration Statement") filed with the Securities and Exchange 
Commission in connection with the registration under the Securities Act of 
1933, as amended (the "Securities Act"), of up to five million shares of the 
Company's common stock, par value $.01 per share ("Common Shares"), which 
Common Shares may be sold by the Company from time to time pursuant to the 
CRIIMI MAE Inc. Dividend Reinvestment and Stock Purchase Plan, as set forth 
in the prospectus which forms a part of the Registration Statement (the 
"Prospectus").  This opinion letter is furnished to you at your request to 
enable you to fulfill the requirements of Item 601(b)(8) of Regulation S-K, 
17 C.F.R. Section . 229.601(b)(8), in connection with the Registration 
Statement. 

     In issuing this opinion, we have examined (1) the Registration 
Statement, including the Prospectus, (2) the Company's Articles of 
Incorporation, as amended, and (3) such other corporate records, including 
the resolutions of the Company's Board of Directors, and such other documents 
as we have deemed necessary in order to express the opinions set forth below. 
 In our examination we have assumed the genuineness of all signatures and the 
authenticity of all documents submitted to us as originals and the conformity 
to all originals of all documents submitted to us as copies.  The opinions 
set forth in this letter are premised on certain written representations of 
the Company contained in a letter to us of even date herewith.

     In rendering our opinion, we have considered the applicable provisions 
of the Internal Revenue Code of 1986, as amended (the "Code"), Treasury 
regulations promulgated thereunder ("Treasury Regulations"), relevant 
judicial authorities, rulings of the United States Internal Revenue Service 
(the "Service"), and such other authorities as we deemed relevant.  The Code, 
Treasury Regulations, judicial decisions, rulings and other authorities that 
we have considered are subject to change at any time and with retroactive 
effect.  A change in any of the authorities upon which our opinion is based 
could affect our conclusions. Moreover, relevant laws could change in a 
manner that could adversely affect the Company or its stockholders.  We 
undertake no obligation to inform you of any such change in the law.  We have 
not been requested to opine, and we have not opined, as to any issues other 
than those expressly set forth herein. Capitalized terms used in this opinion 
letter and not otherwise defined are as defined in the Prospectus.  

     The Company is intended to qualify as a real estate investment trust 
("REIT") under the Code.  Based upon and subject to the foregoing, it is our 
opinion that:

     (1)  the Company was organized and has operated in conformity with the
          requirements for qualification and taxation as a REIT under the Code
          for each of the taxable years it has been in existence, and the
          Company's current organization and method of operation will enable it
          to continue to meet the requirements for qualification as a REIT for
          each of its subsequent taxable years; and 

     (2)  the discussions in the Registration Statement and Prospectus under the
          heading "CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS" are
          correct in all material respects and fairly summarize the United
          States federal income tax considerations that are likely to be
          material to a holder of Common Shares of the Company.

     The Company's qualification as a REIT under the Code will depend upon the
Company's ability to meet, 

<PAGE>

CRIIMI MAE Inc.
December 1, 1997
Page 2

through actual operating results, distribution levels, diversity of stock 
ownership and the various income and asset qualification tests imposed under 
the Code.  Such operating results may not be reviewed by us as counsel, and 
accordingly, no assurance can be given that the actual results of the 
Company's operations for any one taxable year will satisfy the requirements 
under the Code for REIT qualification.  Moreover, certain aspects of the 
Company's operations have not been considered by the courts or the Service.  
There can be no assurance that a court or the Service will agree with our 
opinion.  In addition, qualification as a REIT depends on future transactions 
and events that cannot be known at this time. 

     For a discussion relating the law to the facts, and the legal analysis 
underlying the opinions set forth in this letter, we incorporate by reference 
the discussion of federal income tax issues in the sections of the 
Registration Statement and the Prospectus under the heading "CERTAIN UNITED 
STATES FEDERAL INCOME TAX CONSIDERATIONS."

     We hereby consent to the filing of this opinion as an exhibit to the 
Registration Statement and to all references to our firm in the Registration 
Statement.  In giving this consent, we do not admit that we come within the 
category of persons whose consent is required under Section 7 of the 
Securities Act or the rules promulgated thereunder.

     This opinion is rendered solely for your benefit in connection with the 
transactions described above upon the understanding that we are not hereby 
assuming any professional responsibility to any other person.  Except as 
provided in the preceding paragraph, this opinion may not be relied upon by 
any other person and this opinion may not be used, disclosed, quoted, filed 
with a governmental agency or otherwise referred to without our express prior 
written consent.  The opinions expressed in this letter are limited to the 
matters expressly set forth herein, and no other opinions should be inferred 
beyond the matters expressly stated herein.

                              Very truly yours,

                              /s/ Swidler & Berlin, Chartered              
          
                              SWIDLER & BERLIN, CHARTERED



 
<PAGE>


                                                                    Exhibit 23.1



                      CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


As independent public accountants, we hereby consent to the incorporation by 
reference in this registration statement of our report dated February 17, 
1997 included in the Annual Report of CRIIMI MAE Inc. on Form 10-K for the 
year ended December 31, 1996, and to all references to our Firm included in 
or made a part of this registration statement.

                     /s/ ARTHUR ANDERSEN LLP

Washington, D.C.
December 1, 1997 


<PAGE>

                                                      Exhibit 24.1

                                  POWER OF ATTORNEY

     KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature 
appears below constitutes and appoints William B. Dockser and H. William 
Willoughby, and each of them severally, as his true and lawful 
attorneys-in-fact and agents, with full power of substitution and 
resubstitution, for him and in his name, place, and stead, in any and all 
capacities, to sign any and all amendments (including post-effective 
amendments) to this Registration Statement, and to file the same, with all 
exhibits thereto, and other documents in connection therewith, with the 
Securities and Exchange Commission, granting unto said attorneys-in-fact and 
agents, full power and authority to do and perform each and every act and 
thing requisite and necessary to be done in connection therewith, as fully to 
all intents and purposes as he or she might or could do in person, hereby 
ratifying and confirming all that said attorneys-in-fact and agents or any of 
them, or of his or her substitute or substitutes, may lawfully do or cause to 
be done by virtue hereof.

/s/  Garrett G. Carlson            December 1, 1997
     ----------------------
     Garrett G. Carlson  
     Director


/s/  Larry H. Dale                 December  1, 1997
     ----------------------
     Larry H. Dale
     Director


/s/  Robert J. Merrick             December  1, 1997
     ----------------------
     Robert J. Merrick
     Director


/s/  G. Richard Dunnells           December  1, 1997
     ----------------------
     G. Richard Dunnells
     Director


/s/  Cynthia O. Azzara             December  1, 1997
     ----------------------
     Cynthia O. Azzara
     Chief Financial Officer
     (Principal Financial and 
     Accounting Officer)


<PAGE>

                                   CRIIMI MAE Inc.
                                           
                     Dividend Reinvestment and Stock Purchase Plan
                                    Enrollment Form

Please print all items except signatures. QUESTIONS? Call Registrar & 
Transfer Company (the "Agent") toll-free at 1-800-998-9151. Mail your 
completed Enrollment Form in the courtesy envelope provided. Capitalized 
terms used herein but not otherwise defined have the meanings given to them 
in the Prospectus that sets forth the description of the CRIIMI MAE Inc. 
Dividend Reinvestment and Stock Purchase Plan (the "Plan").  

A.  ENROLLING IN THE PLAN

Please check one box and provide the requested information. This form is not 
to be used for optional cash payments greater than $10,000 or initial cash 
investments greater than $10,000.
     
/ / I wish to enroll. My dividend reinvestment participation option is 
    indicated under Section C below.

/ / I am currently a holder of the Company's common stock ("Common Shares") 
    and wish to enroll by making an optional cash payment under the Plan. I 
    have enclosed a check or money order for $_____________($100 minimum/
    $10,000 maximum monthly) payable to "Registrar & Transfer Company."  I 
    acknowledge that my payment must be received by the Agent no later than 
    12:00 p.m. (noon) Eastern time on the Trading Day immediately preceding the
    commencement of the relevant Pricing Period as described in Schedule A of
    the Prospectus. I also acknowledge that no interest will be paid to me by
    the Company or the Agent on optional cash payments held pending investment
    or to be returned to me.  

/ / I wish to enroll by making an initial cash investment under the Plan. I 
    have enclosed a check or money order for $_____________($500 minimum/
    $10,000 maximum) payable to "Registrar & Transfer Company."  I acknowledge 
    that my payment must be received no later than 12:00 p.m. (noon) Eastern 
    time on the Trading Day immediately preceding the commencement of the 
    relevant Pricing Period as described in Schedule A of the Prospectus. I 
    also acknowledge that no interest will be paid to me by the Company or the 
    Agent on initial cash investments pending investment or to be returned 
    to me.

If your Common Shares are being held by your broker and you wish to 
participate in the Plan, your Common Shares can be enrolled through your 
broker. Tell your broker the Plan is eligible for DTC Dividend Reinvestment 
Services and to request a Broker and Nominee Form from the Agent.

B. YOUR MAILING ADDRESS

Please provide your mailing address below. We must have a complete address to 
process your enrollment.

- -------------------------------------------------------------
   First Name                 M.I.           Last Name

- -------------------------------------------------------------
  Address                                   Apartment Number
  
- -------------------------------------------------------------
   City                 State     Zip Code       Country 
                                           
     Please provide your day and evening phone numbers to assist us in 
processing your enrollment.

Daytime Phone: (     )
                      -----------------------------

Evening Phone: (     )
                      -----------------------------

C. DIVIDEND REINVESTMENT

You may choose to reinvest all, part or none of the dividends paid on Common 
Shares held by you in certificate form. Please check one of the following 
boxes and provide the requested information.

/ / FULL DIVIDEND REINVESTMENT:  The Agent will apply cash dividends on all 
    Common Shares held in certificate form by you and all cash dividends on 
    Plan Shares, together with any optional cash payments or initial cash
    investment, toward the purchase of additional Common Shares.
    
/ / PARTIAL DIVIDEND REINVESTMENT:  The Agent will apply cash dividends on the
    following whole number of Common Shares held in certificate form by you and
    all cash dividends on Plan Shares, together with any optional cash payments
    or initial cash investment, toward the purchase of additional Common
    Shares:   ______ Common Shares
    
/ / OPTIONAL CASH PAYMENT and INITIAL CASH INVESTMENT ONLY:  You will continue 
    to receive cash dividends on Common Shares held in certificate form by you 
    in the usual manner. However, the Agent will apply all cash dividends on 
    Plan Shares, together with any optional cash payments or initial cash 
    investment received from you, toward the purchase of additional Common 
    Shares.

                     - Please complete the reverse side of form -


<PAGE>

                    Dividend Reinvestment and Stock Purchase Plan
                           Enrollment Form CRIIMI MAE Inc.
                                           
D.  YOUR ACCOUNT REGISTRATION               Please Print Clearly

/ / INDIVIDUAL OR JOINT. Joint accounts will be presumed to be joint tenants 
    unless restricted by applicable state law or otherwise indicated. Only one 
    Social Security Number is required for tax reporting.

- -------------------------------------------------------------
  Owner's First Name            M.I.            Last Name  

- -------------------------------------------------------------
  Owner's Social Security No.

- -------------------------------------------------------------
  Joint Owner's First Name      M.I.              Last Name


/ / CUSTODIAL.  A minor is the beneficial owner of the account with an adult
    custodian managing the account until the minor becomes of age, as specified
    in the Uniform Gifts/ Transfers to Minors Act in the minor's state of
    residence.

- -------------------------------------------------------------
  Custodian's First Name        M.I.              Last Name

- -------------------------------------------------------------
  Minor's First Name            M.I.              Last Name

- --------------------------------   ---------------------------
  Minor's Social Security No.       Minor's State of Residence       

/ / TRUST.  Account is established in accordance with provisions of 
    trust agreement.

- ---------------------   ---------------------  ---------------
Trustee Name               Name of Trust         Trust Date

- ---------------------   --------------------------------------
 Tax ID Number                      Beneficiary


/ / CORPORATION, PARTNERSHIP or OTHER ENTITY.

- ----------------------  -------------------------------------
  Business Name                  Tax ID Number


PLEASE BE SURE TO COMPLETE AND SIGN THIS FORM.

E.  SIGNATURES     

By signing this form, I request enrollment, certify that I have received and 
read the Prospectus describing the CRIIMI MAE Inc. Dividend  Reinvestment and 
Stock Purchase Plan and agree to abide by the terms and conditions of the 
Plan. I hereby appoint Registrar & Transfer Company as my agent to apply 
dividends and any optional cash payments and initial cash investment I may 
make to the purchase of Common Shares under the Plan. Further, I understand 
that no interest will be paid to me by the Company or the Agent on dividends, 
initial cash investments or optional cash payments held pending reinvestment 
or investment or to be returned to me.  I understand that I may revoke this 
authorization at any time by written notice to Registrar & Transfer Company. 
All joint owners must sign.

Under the penalties of perjury, I also certify that: A.  The number shown on 
this form is my/our correct Social Security Number or Taxpayer ID Number.  B. 
 I am not subject to backup withholding either because (1) I have not been 
notified by the Internal Revenue Service ("IRS") that I am subject to backup 
withholding as a result of a failure to report all interest or dividends, or 
(2) the IRS has notified me that I am no longer subject to backup 
withholding. (Check here ___ if you have been notified by the IRS that you 
are subject to backup withholding because of underreporting of interest or 
dividends on your tax returns.)

- --------------------------------------  ---------------------------------------
 Signature                   Date          Signature                    Date

You may authorize automatic monthly deductions from your personal bank 
account. The Agent will automatically debit your bank account on or about the 
fifteenth of each month and invest these deductions in Common Shares. To 
initiate these deductions, please complete this section of the form and 
include a voided check on the account you wish to be debited. Please note 
that the automatic debit will not be in effect until the month following the 
receipt of this form.

Amount to be deducted: 
                       -------------------------
(minimum  $100/ maximum $10,000 per month)

- --------------------------------------  ---------------------------------------
Signature                   Date          Signature                     Date

                      QUESTIONS? Call toll-free 1-800-998-9151
          RETURN TO : Registrar & Transfer Company, ATTN: CRIIMI MAE DRSPP
              Post Office Box 1010, Cranford, New Jersey 07016-1010     





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission